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OPTIMIZATION OF PORCINE BUCCAL MUCOSA FOR IN VITRO
EVALUATION

Abstract

by Upendra D. Kulkarni
University of the Pacific
2007

Porcine buccal mucosa has been extensively used as in vitro model to study the
permeability of drugs and assess their potential to deliver through buccal route. Porcine
buccal mucosa is found to be very similar to human oral mucosa in structure and
function. However, the in vitro permeation studies across porcine buccal mucosa show
high variability which is mostly due to the various experimental and biological variables
that are often overlooked while conducting such studies.
The precise nature of the permeability barrier offered by the various tissue layers of
buccal mucosa was investigated in this study. It was observed that the permeability of
model diffusants decreased significantly with an increase in the connective tissue layer.
However, the epithelium offered a stronger barrier to permeation of all diffusants studied
at mucosal thickness of up to 500 pm. The epithelium acted as a stronger barrier for
hydrophilic diffusants when compared to lipophilic diffusants.
It was also observed that the permeability of model diffusants was significantly
higher in the region behind lip when compared to the middle cheek region which is due to
lower epithelial thickness in that region. Porcine buccal mucosa retained its integrity in
Kreb's bicarbonate Ringer solution at 4 °C for 24 hours and many other storage
vi

conditions resulted in loss of epithelial integrity. Separation of epithelium from the
underlying connective tissue by heat treatment, did not adversely affect its permeability
and integrity characteristics.
Influence of experimental temperature on the permeability of model compounds
across porcine buccal mucosa was also investigated in vitro. An exponential relationship
was observed between the apparent permeability and temperature. It was found that the
activation energy of diffusion of the model compounds decreased linearly with increasing
distribution coefficients across porcine buccal mucosa. This suggested that the buccal
mucosa acted as a stronger barrier for diffusion of hydrophilic diffusants when compared
to the lipophilic diffusants.
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CHAPTER 1

1. INTRODUCTION

1.1

Buccal Drug Delivery

The oral route is the most commonly employed route for administration of
medications. Due to the limitations associated with this route, such as high first pass
metabolism of drugs, and chemical and enzymatic degradation, other routes are being
investigated. The alternative routes for delivery of drugs are transdermal route, mucosal
routes, pulmonary route etc. These routes overcome many of the drawbacks associated
with peroral and parentaral routes of delivery. Still these routes are associated with some
problems which are needed to be overcome before they can be used as drug delivery
routes. Buccal mucosa appears to be better in terms of permeability, surface area,
compliance etc when compared to the other mucosal and transdermal routes of delivery.
The transdermal route has lower permeability and vaginal and rectal routes have limited
surface area and problems with patient compliance. The other mucosa such as nasal
mucosa has problems with continuous administration due to the fragile nature of ciliary
cells and also has a limited surface area. Buccal mucosa compared to all these routes of
administration has better patient compliance and good accessibility. Frequent exposuie
to food materials and rapid cell turnover make the buccal mucosa more resistant to tissue
damage and irritation compared to other mucosal routes of administration.

These comparative advantages make buccal mucosa very attractive route for
systemic drug delivery.

1.1.1

Anatomy and Physiology of Buccal Membrane
The buccal mucous membrane consists of a squamous stratified epithelium at the

surface supported by a fibrous connective tissue as shown in Figure 1.1. The epithelium
protects the underlying tissues and organs against mechanical and chemical damage
whereas the connective tissue provides mechanical support and nutrition for the
epithelium (1). The buccal epithelium does not have a cornified or keratinized surface
layer and hence it is more permeable than the keratinized masticatory regions or oral
cavity or skin. A similar non-keratinized tissue lines the human esophagus.
The epithelium is connected with the connective tissue via a single layer of
basement membrane also known as the basal lamina. The connective tissue comprises of
lamina propria and sub mucosa. The buccal epithelium is composed of 40-50 cell layers
and similar to the stratified squamous epithelium found in other parts of the body. The
epithelial layers increase in size and flatten out as they reach the superficial layers. The
basal layer is composed of cuboidal cells followed by several layers of flattened cells and
prickle cell layer (2). Lamina propria is composed of collagen fibrils, a supporting layer
of connective tissue, a network of blood capillaries and smooth muscle. Once the drugs
diffuse through the epithelium they enter the systemic circulation through this capillary
network. The thickness of the buccal mucosa has been estimated to be in the range of
500-800 pm.
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Basal Lamina
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J
Figure 1.1 Schematic representation of the anatomical structure of the porcine buccal
mucosa

3

I issue turnover time (i.e., the time taken for the entire thickness of an epithelium
to be replaced) in buccal mucosa is 13 days (1). During maturation and differentiation,
the mature cells in the outer portion of buccal epithelium become large and flat and
possess a cross-linked protein envelope, but they retain nuclei and other organelles, and
do not aggregate to form bundles of filaments as seen in keratinizing epithelia. When the
cells grow and reach towards the outer one third region of the epithelium, membrane
coating granules begin to appear on the surface of cells. These granules contain lipids
which are extruded out in the intercellular space when they fuse with the plasma
membrane of cells. These membrane coating granules are spherical in shape, membranebounded and are about 0.2 microns in diameter (3). These membrane coating granules
lack internal lamellar structure. The superficial layer of buccal epithelium contains an
electroluscent material which represents non-lamellar phase lipid. In contrast, the
keratinized epithelia have the membrane coating granules containing an organized
assembly of lamellar lipids. The absence of organized lipid lamellae in the intercellular
spaces confers greater permeability to the buccal epithelium as compared to the
keratinized epithelium (1).

1.1.2

Advantages of Buccal Drug Delivery (4)
The advantages of delivery of drugs across the buccal mucosa are:

1.

It bypasses hepatic first

pass metabolism and degradation in stomach and

intestines.
2.

It has a large surface area for drug application.

3.

It provides excellent accessibility.
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a. It makes precise dosage form localization possible.
b. It allows localized modification of tissue permeability/inhibition of
protease activity if needed.
c. It can be easily removed in case of emergencies.
4.

The delivery device can be made unidirectional leading to only oral mucosal

absorption.
5.

The delivery device prevents diffusion-limiting mucus buildup.

6.

The buccal mucosa has higher permeability than skin.

7.

It provides better patient compliance than vaginal or rectal routes.

8.

Although less permeable than sublingual mucosa, it acts as a better site for
sustained release delivery.

9.

The oral mucosa is less prone to damage or irritation than nasal mucosa.

10.

Unlike vaginal mucosa, it is not sex-specific.

1.2

Assessing the Buccal Drug Permeation

One of the primary functions of the oral mucosa is to provide a barrier which
protects the underlying tissues from endogenous or exogenous substances present in the
oral cavity. The mucosal barrier also prevents the loss of material from the underlying
tissues into the oral cavity. Despite the existence of a permeability barrier in the
superficial layer of buccal epithelium, it is clear from various permeability experiments
that this is not an absolute barrier and that even relatively large molecules can penetrate
epithelium (5, 6). The rate at which different compounds cross the buccal epithelium
depends on their molecular size, weight, chemical nature, and degree of ionization. It has

therefore been claimed that compounds with different chemical and physical properties
cross the buccal epithelial barrier by different pathways (7, 8). Many studies have been
performed to quantitatively estimate the permeability of drugs across the mucosal barrier
and to understand the mechanisms by which these drugs cross the oral mucosa.

1.2.1

Pathways of Drug Transport across Buccal Mucosa
It is very important to know and understand the biological and physicochemical

nature of the drug absorption process and the mechanisms of drug penetration across the
buccal tissue at the cellular and molecular level. Knowledge of the permeation route
helps in the intelligent design of the permeation enhancer which can control tissue
permeability (9).
Typically buccal mucosa consists of two regions:
a.

Epithelial cell membrane which is essentially lipophilic and

b.

Intercellular space which is considered to be hydrophilic.

The hydrophilic intercellular space is narrow and tortuous around the lipophilic
cell membrane.

Because of the anatomical organization of these hydrophilic and

lipophilic regions, there are two routes for drug transport across the buccal mucosa as
shown in Figure 1.2.
The hydrophilic drugs transport across the buccal mucosa preferentially via the
hydrophilic intercellular space and is called the paracellular route (para - in between). It
is difficult for a hydrophilic compound to penetrate into the lipophilic cell membrane, and
hence the intercellular space is the preferred route for such compounds. The main
limitations of paracellular pathways are limited surface area and tortuous pathways.
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Hence the permeability of such compounds is relatively low with presence of a lag-time
(10).

The lipophilic drugs on the other hand preferentially transverse across the
lipophilic cell membrane and the route is called the transcellular route (trans - across).
This route has a greater surface area and the path length for transcellular route is
relatively short, hence the lipophilic drugs traversing through this route show a high
permeability with little or no lag-time. The main permeability barrier of this route are the
lipids such as triglycerides and cholesterol present in the cells (10).
These two routes contribute to the transport of all diffusants, but one route is
always the major route depending upon the physicochemical properties of the diffusant.
Permeation enhancers are the compounds which increase the rate and extent of
permeation of drugs across oral mucosa and hence allow drug molecules to move with
less resistance.

Depending upon the mechanism of permeation enhancer a drug can

traverse more through paracellular route or through transcellular route. For example,
chelators can complex with calcium ion which is essential to maintain the dimensions of
the intercellular space (11).

Hence they increase the permeability through the

paracellular pathway. Other enhancers like oleic acid and caprylic acid increase cell
membrane fluidity by disrupting the phospholipids domain and hence they increase the
permeability via transcellular pathway (12, 13).
A drug will use the route which offers lowest diffusional resistance.

If the

resistance of a particular route has been decreased by a particular peimeation enhancer
then the drug may switch to that particular route such that a transcellular drug can
become paracellular and vice versa (10).

7

Epithelial cell

Mucus layer

Paracellular route

Transcellular route

Figure 1.2 Schematic representation of the pathways of drug transport across the porcine
buccal mucosa
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1.2.2

In Vitro Permeability Assessment
In vitro permeability studies across porcine buccal mucosa are a useful tool for

assessing the potential of a localized anatomical site as a route for drug delivery. Various
types of diffusion cell assemblies are available to conduct the in vitro buccal permeability
studies: a. Franz diffusion cells
b. Two-chambered flow through diffusion cells
c. Two-chambered side-by-side diffusion cells
d. Ussing chambers
Typically, studies are conducted isothermally at 37 °C by clamping the excised
mucosa between the donor and the receiver chambers. Both the chambers are filled with
a simulated physiological solution such as phosphate buffered saline, and the compound
to be studied is charged on the donor side after sufficient time of equilibration. Samples
of the diffusant solutions are taken at regular intervals and replaced with fresh buffer
solution of equal volume. The amount of the diffusant penetrating the tissue at steady
state is then calculated. This is expressed as the apparent permeability or also known as
the permeability coefficient and is given by the following relation:

P
(vp)

=

Am

(1)

Ax AC x At

P(app) = apparent permeability (cm/s)
Am = mass of diffusant transported through the buccal membrane (pg)
A = diffusional area or area of the exposed tissue in cm
AC = concentration differences between the two surfaces of the membrane (pg/cm3)
At = time (s)
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The advantage of this method is that it allows permeability to be measured
under controlled conditions. For a series of compounds using skin, Franz has shown
good correlation between permeability constants obtained in vitro with in vivo values
(14). However; the in vitro transbuccal permeation studies show high variations in the
permeability data and most of the times is not a true representative of the in vivo
conditions. There is a strong need to optimize the in vitro permeability conditions in
order to obtain permeability values which are more reliable and consistent. It is thus
necessary to study the various variables that may cause variation in the permeability of
diffusant molecules. These variables once determined can be avoided or minimized,
where possible, so that we get an experimental data which is precise and accurate and
true representation of the in vivo situation.

1.2.3

In Vivo Permeability Assessment
There have been a number of in vivo studies to determine oral permeability (15).

In 1967 Beckett and Triggs described the "buccal absorption test" in which a known
quantity of a drug in solution is taken into the mouth, swirled around, and then
expectorated (16). By measuring the drug concentration in the solution before use and
after expectoration, the amount of absorption can be calculated. The major drawback of
this method is that it may lead to a change in the concentration of the drug in the mouth
as a result of salivary secretion. Despite modifications to the above method, it is not able
to provide information on absorption in a specific mucosal region, because the test
solution is swirled in the whole mouth.
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To overcome this problem, Bergman et al., used radiolabeled lidocaine and
monitored the appearance of isotope in either plasma or urine (17, 18). The limitation of
this method was that there was a risk of radioactivity spreading in different mucosal
regions and hence it may not be appropriate in human studies.
Ritschel et al. developed a method wherein small chambers were placed on the
surface of the oral mucosa and were filled with compound under study and the
concentration was monitored (19). This approach overcomes many of the shortcomings
of methods described above and also allow for a defined region and elimination of
salivary juices. However, extremely sensitive assay methods are necessary to detect the
uptake of a compound over the relatively small areas of mucosa that are involved.
The best way to study in vivo permeability is to administer the buccal dosage
forms to human volunteers and measure the plasma concentration of the drug. Pimlott
and Addy placed tablets of isosorbide dinitrate on the hard palate, buccal mucosa, and
sublingually in human volunteers and measured the plasma levels of the drug using gas
liquid chromatography (20).
Due to the inconvenience associated with in vivo study setup, there are limited
examples of in vivo studies and in vitro studies remain the most popular way for the
assessment of transbuccal permeability.

1.3

Statement of the Problem

There is a significant variation in the results of permeation experiments across the
biological membrane. In permeation studies, it has been observed that the permeability
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of a diffusant is not always the same across the porcine buccal membrane. In such
experiments the coefficient of variation (C.V.) is often between 20 and 50%, and one
would occasionally find C.V. as high as 80% or more. For example, the apparent
permeability coefficient (Papp) of T, 3'-dideoxycytidine (Zalcitabine, ddC) was reported
as 0.18*10~6 cm/s in one study by Jun et al. (21) while a Papp of 4.1*10"6 cm/s was
reported in another study by Shojaei et al. (22). Thus there was a 23-fold difference
between the permeabilities of the same drug, viz., ddC across the porcine buccal
membrane. The relatively large C.V. observed in buccal permeation experiment is
mostly due to 'biological variation' or the lack of reproducibility in living animal and use
of varying experimental conditions during such studies. On the other hand, the
variability in chemical, enzymatic and instrumental analyses of compounds is usually
very low and can be avoided if the instrument is sensitive and proper care is taken while
handling the drug compounds. It is therefore, very important to determine the different
variables that are responsible for such a high variation in the permeability experiments.
Once these variables are determined, they can be avoided or minimized. In cases where
it is unavoidable, the permeability data can be normalized with that particular variable
leading to a data which has significantly lower standard deviation and coefficient of
variation.
Each tissue has its distinct and inherent biological characteristics which lead to
different permeability values. These biological characteristics which may differ are the
presence of connective tissue, tissue thickness, and the mucosal region used in the
permeation studies. The different experimental conditions which may be likely to
contribute to the variance in tissue permeability are varying tissue storage conditions,
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different ways of tissue processing before diffusion studies and different temperature
settings during diffusion studies. Some of these variables may also affect the tissue
integrity and hence the permeability of the concerned diffusant molecule. So far, the
effects of these variables have not been explored well enough in the transbuccal
permeation studies.

1.4

Research Hypothesis

Differences in the connective tissue thickness, region of the buccal mucosa,
storage conditions and experimental temperature used in the in vitro permeation studies
cause a high variability in the transbuccal permeation of various diffusants.

1.5

Research Objectives

The three major objectives of this research are to determine
1

The role of epithelium and connective tissue region towards the

permeability barrier.
2

The influence of biological and experimental variables on the in vitro

transbuccal permeation. The variables that need to be evaluated are the mucosal
region, aging/storage time of the tissue, and different tissue processing methods.
3

The effect of experimental temperature on the in vitro transbuccal

permeability of model diffusants of varying physico-chemical characteristics.
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1.6
1.6.1

Specific Aims

To determine whether the variation in the porcine buccal mucosal thickness
result in a significant change in the in vitro permeability of the diffusants.

1.6.2

To determine whether different regions of the buccal mucosa result in
different permeability values.

1.6.3

To determine whether the permeability and integrity characteristics of the
porcine buccal mucosa are comparable between the heat separation and the
surgical method of tissue processing.

1.6.4

To determine whether the permeability and integrity of porcine buccal mucosa
after storage is same when compared to freshly excised tissue.

1.6.5

To determine whether changes in temperatures of the permeation experiments
cause changes in the permeability of the porcine buccal mucosa.
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CHAPTER 2

THE ROLE OF EPITHELIUM AND CONNECTIVE TISSUE REGION
TOWARDS THE PERMEABILITY BARRIER

2.1

Introduction

The buccal route of drug administration overcomes many of the drawbacks
associated with oral route such as high first pass metabolism of drugs, and chemical and
enzymatic degradation. Buccal mucosa has higher permeability than skin and has larger
surface area when compared to the other mucosal routes of delivery. Also, frequent
exposure to food materials and rapid cell turnover make the buccal mucosa more resistant
to tissue damage and irritation compared to other mucosal routes of administration.

One of the primary functions of the oral mucosa is to form a protective barrier for
the underlying tissues from endogenous or exogenous substances present in the oral
cavity. The mucosal barrier also prevents the loss of material from the underlying tissues
into the oral cavity. Despite its function as a permeability bander, various permeability
experiments indicate that the superficial layei of buccal epithelium is not an absolute
barrier and that even relatively large molecules are able to diffuse through the epithelium
and reach a steady state flux (5, 6). The rate at which different compounds cross the
buccal mucosa depends on their molecular size, lipophilicity, and degiee of ionization (7,
8).
15

In permeation studies, it has been observed that the flux of a diffusant varies by as
much as 80 -100% or more between experiments and amongst different reports. For
example, the apparent permeability coefficient (Papp) of 2\ 3'-dideoxycytidine
(Zalcitabine, ddC) was reported as 0.18* 10"6 cm/s in one study by Jun et al. (21) while a
Papp of 4.1 * 10~6 cm/s was reported in another study by Shojaei et al. (22). Jun et al. used
full thickness buccal mucosa whereas, Shojaei et al. used a buccal tissue of thickness in
the range of 600-800 p.. The source of such variability is due to the use of buccal mucosa
of different thicknesses as the permeability barrier of the buccal epithelium is believed to
be located on the top one-third of the epithelium and connective tissue was not believed
to offer significant barrier for transport (23-35). Since the source of variability is the
differences in the thickness of buccal mucosa used in the in vitro studies, the barrier
property of epithelium and connective tissue needs to be clearly defined and delineated.
Such an understanding will result in the accurate interpretation of permeability data and
comparison amongst the results from multiple sources. In the current study, a hypothesis
that the in vitro transbuccal permeability of diffusant molecules is significantly altered by
the mucosal tissue's thickness and connective tissue acts as a significant biological
barrier to the permeation of diffusants of varying physico-chemical characteristics was
tested.

The influence of tissue thickness on the permeability characteristics of diffusant
molecules of varying lipophilicities was investigated in this study. The relative
contribution of the epithelium and connective tissue as a barriei for the permeability of
diffusants was assessed using a bilayered diffusion model.
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2.2
2.2.1

Theory

Relation between tissue thickness and permeability

According to Fick's law of diffusion (36), the flux of a compound can be written
as,

where, Jss = steady state flux (pg-cm/s)
K = partition coefficient of the diffusant between the membrane and diffusant
solution
D = diffusivity of a diffusant (cm /s)
C = concentration of the diffusant (pg)
h = thickness of the membrane (cm)
As shown in the equation (1), as thickness of the mucosa increases, the steady
state flux of the diffusant decreases. When the partition coefficient of the diffusant
remains constant; a plot of the reciprocal of tissue thickness as a function of diffusant
permeability yields a linear relationship.
The permeability P can be calculated as (37):
p=

AC

(3)

where, AC is the concentration difference between the two surfaces of the membrane.
The diffusion coefficient of a diffusant across the epithelium can be calculated
from the experimentally known values of lag time and permeability of the diffusants
across the buccal epithelium. The time lag for the diffusant to cross the barrier
membrane is determined from the steady state portion of the cumulative amount
17

permeated against time curve and is the intercept of this linear portion on the time axis.
The following equation is used to determine the diffusion coefficient across a
homogeneous membrane such as the epithelium (36).

A =7\

(4)

6 xtL

Where Di = diffusion coefficient of epithelium (cm2/s)
h = thickness of the epithelial membrane (cm)
tL = lag time of the diffusant to cross the epithelium (s)
Since the buccal mucosa is a bilayer membrane with the epithelial layer and the
connective tissue layer in intimate contact with each other (See Figure 2.1), their
respective permeability values are given by the equations:

P

r

= />. =

AC£

c

(5)
A CC

where, Pe = epithelial permeability

JSS(E) = steady state flux across the epithelial membrane
ACe = concentration difference between the two surfaces of the epithelial
membrane (Cn and C12)
Pc = connective tissue permeability

Jss(C) = steady state flux across the connective tissue
/\(y(- = concentration difference between the two surfaces of the connective tissue
(C21 and C22)
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PE

Pc

C12

Epithelium
Connective
tissue

• Jss

Figure 2.1 Schematic of epithelium and connective tissue in series

19

Rearranging the above equations we get,

aC c = % a
RC

(6)
"E

The partition coefficient, K of the diffusant between the interface of the epithelium and
the connective tissue is given by the equation:
C E = K XC C

(7)

When the partition coefficient K equals unity, Ce = Cc and we can write:
AC£ + ACc = (C12 - Cn) + (C22 - C21) = ACr

(8)

where ACj = the total concentration difference between the two surfaces of the mucosal
bilayer membrane.
Substituting the values of equation (6) in equation (8), will result in:
JSS(E) j JSS(C) _ JSS(T )
RPE
£P
1P(T)
C

^

where, JSs(T) and P(T) are the steady state flux and permeability across the entire buccal
bilayer respectively.
At steady state, the flux through the epithelium and connective tissue should be the same
and equal to the total flux through the bilayer membrane. Hence,
j

J SS(E)

- j
= j
~ J SS(C) J (SS)T

(10)

Dividing equation (9) by Jss, we get

_L-_L
iPE

Pc
Jr

(11)

PT

Therefore the total permeability of buccal mucosa is due to addition of permeability of
epithelium and connective tissue placed in series (21). The total permeability of a
mucosa of certain thickness and the epithelial permeability will be determined from the
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permeation experiments. With this equation, the permeability of connective tissue can be
calculated and hence the relative contribution of the connective tissue and the epithelium
in providing a permeability barrier can be estimated.
The lag time to reach steady state for a bilayered barrier membrane is given by the
following equation (36)

(12)

L

where tL = lag time for the diffusant to cross the bilayered barrier membrane (s)
hi = thickness of epithelium (cm)
h2 = thickness of connective tissue region (cm)
2

D( = diffusion coefficient of epithelium (cm /s)
D2 = diffusion coefficient of the connective tissue region (cm2/s)
Ki = partition coefficient of the diffusant in the epithelium
K2 = partition coefficient of the diffusant in the connective tissue
When the partition coefficients, Ki — K2, the above equation reduces to

hi

hi

6D,2

_

o
6 A2

hfcjfa +h

'

)

(13)

2D,A

h

h2

D\

D2

—— H

2

— „ ^

—

Rearranging the above equation in quadratic form results in

hxh2(hx + h
" ( ^ 0 ]*

6D:

D

l

2

h

)
]* D

~ K h 2 > L )+
2D,

D,
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2

+

=

6

0

(14)

Solving the above quadratic equation for D2 will yield,

2D,

D2 =

f

2D,

'

6/1 J

b,\
D,

\
6

.(15)

Q/ ^1 _ tL,\ ,
6D,2
£>t

This equation can be used to determine D2, the diffusion coefficient of the
connective tissue. The diffusion coefficient of the epithelium, Di can be calculated by
using the experimental permeability values of the epithelium and lag time and
substituting them in the equation (3). Knowledge of the diffusion coefficient of the
epithelium and the connective tissue will help in better understanding the nature and
extent of the permeability barrier offered by the respective membranes.

2.3

2.3.1

Materials and Methods

Materials

Buspirone, bupivacaine, antipyrine and caffeine were obtained from SigmaAldrich, (St. Louis, MO, USA) and were used as model compounds since they have
different lipophilicities and physicochemical properties which are summarized in Table
2.1. Tissue integrity was assessed by FD-20 [fluorescein isothiocyanate (FITC) - labeled
dextran of molecular weight 20,000 daltons] which is an established integrity marker in
22

buccal mucosa. Acetonitrile and methanol were obtained from VWR and were of HPLC
grade.

2.3.2

Tissue Preparation

Buccal mucosa was obtained from freshly sacrificed pigs of a local ranch (Long
Ranch Inc.). The mucosa was transported to the laboratory in isotonic phosphate buffer
(pH 7.4) and used within two hours of animal sacrifice. The majority of underlying
connective tissue was removed with the help of a scalpel blade and then the remaining
buccal mucosa was carefully trimmed with the help of surgical scissors to uniform
thicknesses of about 250. ±25. pm, 400. ±25. pm, 500. ±25. pm, 600. ±25. pm and 700.
±25. pm.
The buccal mucosa of about 250. ±25. pm essentially represented the epithelial
region only while the mucosae of higher thickness represented the presence of both the
epithelium and the connective tissue regions. The use of dermatome for the slicing of the
tissue was avoided since it requires prior freezing which may compromise the barrier
properties of the epithelium as well as the connective tissue region of the buccal mucosa.
The thickness of the tissues was measured with the help of a digital screw gauge. This
helped to minimize variations between tissue specimens.
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2.3.3

Permeation Assembly Setup
The buccal mucosa was mounted on the vertical Franz diffusion cells in such a

way that the epithelium faced the donor chamber and the connective tissue region faced
the receiver chamber. A constant temperature of 37 °C was maintained throughout the
experiment in both the receiver and donor chambers to mimic the in vivo environment.
This was accomplished by mounting the diffusion assembly setup in a 37 °C walk-in
incubator room. The tissues were allowed to equilibrate with buffer for fifteen minutes
before commencement of the diffusant permeability experiment. The permeability
experiments were carried out using phosphate buffered saline (PBS) with pH 7.4 in the
receiver chamber and pH 6.8 in the donor chamber to mimic the in vivo physiological pH
conditions(45). Permeation of the model diffusant compounds across the buccal mucosa
was determined by collecting 1 mL aliquots at every thirty minutes for up to four hours.
In the case of bupivacaine, the sampling was done every hour up to eight hours. All
experiments were conducted in triplicates.

2.3.4

Quantification of Model Diffusants
Known concentrations of model diffusants (antipyrine, 50. mg/mL, buspirone 0.5.

mg/mL, bupivacaine 1. mg/mL and caffeine 20. mg/mL) were prepared using PBS at pH
6.8 and used as donor formulations. Steady state flux values of model diffusants across
buccal mucosa were calculated from the slope of the linear portion of the cumulative
amount permeated versus time plots. Concentration of the model diffusants in the
permeation samples were quantified by using high performance liquid chromatography
(HPLC) consisting of Waters 590 HPLC pump, WISP 715 auto sampler, Shimadzu SPD25

M10AVP UV detector, and EZ chromatography software. A reverse phase Ci8 — column
(length 250 mm, thickness of capillary bore 5microns) was used to elute the diffusants.
The HPLC conditions were optimized and developed for analysis of individual diffusants
as shown in the Table 2.2.

2.3.5

Histological Examination
The histological changes in the buccal tissues of differing mucosal thicknesses

were evaluated by sectioning them carefully and fixing in vials containing 10% buffered
formalin for 1 day at room temperature. An optimized procedure was adapted for
histological studies using the paraffin technique. Tissue samples were successively
dehydrated with increasing series of ethanol concentrations - 30%, 50%, 70% and
absolute alcohol. This was followed by embedding in xylene and finally in paraffin.
Paraffin cubes were sliced into thin slides of 5. pM thickness using a microtome (Model
820, American Optical Co., Buffalo, NY) and then stained with Harris Hematoxylin and
Eosin Y Stain. The stained slides were examined under a Nikon Eclipse E800 light
microscope with planfluor objective lenses (Nikon, Inc., Melville, NY). Two microscope
slides per tissue sample were prepared and examined. An Optronics DEI-750 three-chip
CCD camera (Optronics Engineering, Goleta, CA) was used to capture images. Images
were processed by Image-Pro Plus software (Media Cybernetics, Silver Spring, MD).
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2.4

2.4.1

Results

Transmucosal Permeation Studies
The permeability of the model diffusants across buccal mucosa of thickness 250.

±25. um, 400. ±25. pm, 500. ±25. pm, 600. ±25. pm, and 700. ±25. pm was determined.
The representative plots of cumulative amount permeated vs time profile are shown in
Figures 2.2, 2.3, 2.4 and 2.5 for buspirone, bupivacaine, antipyrine and caffeine
respectively. As can be seen in the figures, the amount of diffusant permeating across the
buccal mucosa decreased with an increase in mucosal tissue thickness.
The steady state flux and the permeability values were calculated from the slopes
of the linear region of the cumulative amount permeated vs. time plots. As shown in
Table 2.3, an increase in mucosal thickness of about 100 pm significantly decreased the
PT of the three model compounds (p<0.05).
Figure 2.6 shows the relationship between the membrane permeability and the
reciprocal of tissue thicknesses. A linear relationship is observed between the
permeability of the diffusant and the inverse of tissue thickness with an R2 of 0.95, 0.91,
0.95 and 0.90 for buspirone, bupivacaine, antipyrine, and caffeine, respectively. The
figure also shows that the slope is much steeper for lipophilic drugs such as buspirone
and bupivacaine when compared to the relatively hydrophilic drugs such as antipyrine
and caffeine.
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Figure 2.2 Cumulative mass permeated vs. time profile for buspirone permeation across
porcine buccal mucosa of varying thicknesses (n=3)
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Figure 2.3 Cumulative mass permeated vs. time profile for bupivacaine permeation
across porcine buccal mucosa of varying thicknesses (n—3)
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Figure 2.4 Cumulative mass permeated vs. time profile for antipyrine permeation across
porcine buccal mucosa of varying thicknesses (n=3)
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Figure 2.5 Cumulative mass permeated vs. time profile for caffeine permeation across
porcine buccal mucosa of varying thicknesses (n=3)
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The lelative contribution of the epithelium and the connective tissue towards the
permeability of a compound across the complete buccal mucosa was determined from
equation (10) at each level of tissue thickness. Up to a total mucosal thickness of 500
pm, the permeability of epithelial region was lower than that of the connective tissue
region for buspirone, bupivacaine and caffeine (Tables 2.4, 2.5, 2.7). In case of
antipyrine, the permeability of epithelial region was lower than that of the connective
tissue region up to a total mucosal thickness of 600 pm (Table 2.6).
The barrier contribution of the connective tissue region increased significantly
with every 100 pm increase in total mucosal thickness. The barrier provided by the
connective tissue region was significantly higher than that provided by the epithelial
region at a total mucosal thickness of 700 pm in the case of all the diffusants (Figures
2.7,2.8,2.9, and 2.10).
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Table 2.4 Relative contribution of epithelium and connective tissue region towards the
permeability of buspirone

Buspirone Permeability (cm/sec)
Thickness (pm)
Pi

Pc

700

0.925 x 10"5

1.45 x 10"5

600

1.254 x 10"5

2.48 xlO"5

500

1.54 x 10"5

3.93 xlO"5

400

1.784 xlO"5

6.05 x 10"5
?E - (2.529±0.18) x 10

Surgically trimmed epithelium (250pm)

(* indicates p < 0.05 when compared to control) (n-3)
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Figure 2.7 Relative contribution of the permeability barrier offered by epithelium and
connective tissue region to buspirone
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Table 2.5 Relative contribution of epithelium and connective tissue region towards the
permeability of bupivacaine:

Bupivacaine Permeability (cm/sec)

Thickness
(pm)

Pi

Pc

700

0.786 x 10"5

0.112 x 10"5

600

1.304 x icr5

2.567 x 10"5

500

1.680 x 10"5

4.587 x 10-5

400

1.890 x 10"5

6.579 x 10'5
PE - (2.65 ± 0.12) x 10 3

Surgically trimmed epithelium (250pm)

(* indicates p < 0.05 when compared to control) (n=3)
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Figure 2.8 Relative contribution of the permeability barrier offered by epithelium and
connective tissue region to bupivacaine
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Table 2.6 Relative contribution of epithelium and connective tissue region towards the
permeability of antipyrine

Thickness (pin)
700
600

„
"t
2.249 x 10"6
2.696 x 10"6

Antipyrine Permeability (cm/sec)
Pf
4.451 x 10"6
6.625 x 10"6

500

3.132 x 10"6

10.056 x 10"6

400

3.644 x 1Q"6

18.333 x 10"6

Surgically trimmed epithelium (250pm)

Pe - (4.54 ± 0.58)x 10

(* indicates p < 0.05 when compared to control) (n-3)
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Figure 2.9 Relative contribution of the permeability barrier offered by epithelium and
connective tissue region to antipyrine
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Table 2.7 Relative contribution of epithelium and connective tissue region towards the
permeability of caffeine

Caffeine Permeability (cm/sec)
Thickness (jam)
Pc_
700

3.242 x 10"6

4.989 x 10~6

600

4.507 x 10"6

8.810 x 10"6

500

6.027 x 10"6

17.357 x 10"6

400

7.215 x 10"6

33.026 x 10"6

Surgically trimmed epithelium (250pm)

Pe - (9.24 ± 0.76) x 10

(* indicates p < 0.05 when compared to control) (n 3)
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Figure 2.10 Relative contribution of the permeability barrier offered by epithelium and
connective tissue region to caffeine
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The lag time also increased significantly (p<0.05) for all the model diffusant
molecules with an increase in mucosal thickness as the diffusants were required to
traverse longer distance before attaining steady state flux (Table 2.8). It was also
observed that the lag time for lipophilic diffusant like buspirone was lower than the other
hydrophilic diffusants antipyrine and caffeine, because of its higher partitioning into the
buccal membrane (Figure 2.11, 2.12, 2.13 and 2.14).
The diffusion coefficient of the epithelium for the model diffusants was calculated
from their lag times using equation (3). The diffusivity of the connective tissue region
was determined using the equation (14). As observed in the Figure 2.15, the diffusivity
of the epithelial region is significantly lower than the diffusivity of the connective tissue
region for all model diffusants studied (p < 0.05). This indicates that epithelium acts as a
stronger barrier to diffusion of diffusants when compared to the connective tissue region.
When a graph of epithelial diffusivity is plotted against the logD values of the
diffusants at pH 6.8, a linear relationship is observed which shows that the lipophilic
compounds diffuse more easily through the epithelium when compared to the hydrophilic
compounds (Figure 2.16).

2.4.2

Histology Studies
Figure 2.17 (a to d) show the histological specimens of the porcine buccal mucosa

at various thicknesses of about 250 pm, 400 pm, 500 pm, and 600 pm respectively. The
thickness of the epithelial region remained fairly constant but the thickness of the
connective tissue region increased with an increase in the total mucosal thickness.
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Table 2.8 Effect of mucosal thickness on the lag time of model diffusants
Mucosal

Lag time (minutes)

thickness

Buspirone

Bupivacaine

Antipyrine

Caffeine

250 pm

(12.92±0.68) *

(15.52±1.39) *

(40.47±1.39) *

(33.34±7.00) *

400 pm

(41.55±3.52) *

(53.77±5.47) *

(48.75±3.24) *

(45.47±3.86) *

500 pm

(48.68±1.53) *

(67.27±0.84) *

(55.59±2.73) *

(54.15±2.59) *

600 pm

(53.43±2.52) *

(73.36±3.97) *

(60.46±2.28) *

(61.94±2.99) *

700 pm

(70.97±1.71) *

(83.85±2.84) *

(68.37±1.04) *

(83.44±7.54) *

( * indicates p < 0.05) (n=3)
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igure 2.11 Lag time for buspirone at various mucosal thicknesses
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Figure 2.12 Lag time for bupivacaine at various mucosal thicknesses
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Figure 2.13 Lag time for antipyrine at various mucosal thicknesses
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Figure 2.17b Histological sections of mucosa of epithelium of 400 pm thickness (E
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Figure 2.17c Histological sections of mucosa of epithelium of 500 pm thickness (E epithelial region, C = connective tissue region)
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Figure 2.17d Histological sections of mucosa of epithelium of 600 pm thickness (E epithelial region, C = connective tissue region)
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Discussion

According to Squier and Hall the superficial cell layers of buccal epithelium
corresponding to approximately the outer one-quarter to one-third of the epithelium form
a permeability barrier for the transport of molecules (46, 47). This conclusion was
reached based on a study in which rabbit buccal mcosal tissues were incubated in horse
radish peroxide (HRPO) solution. HRPO (molecular weight 44,000 daltons) was used as
a tracer and the incubation was carried out for one hour. Since the incubation was
carried out for only one hour and HRPO is a large hydrophilic molecule it could, most
likely, have been trapped in the outer epithelial region. Furthermore, since rabbit buccal
tissue is para-keratinized, HRPO may not have diffused into deeper layers (4). Hence,
the conclusion about the existence of permeability barrier in the upper one third region of
the buccal mucosa using HRPO and rabbit buccal mucosa may not be accurate. In
another study, verapamil was found to form a depot in the upper layers of the mucosal
membrane in human volunteers. However, these diffusion experiments were carried out
for only 16 minutes, which might not be sufficient time period to reach equilibrium in the
membrane to conclude its barrier property (48). There are some other findings that
concluded the basal lamina might play a role as a major absorption barrier (49, 50).
Experiments using fluorescien isothiocyanate, a hydrophilic marker indicated that the
major barrier to penetration is located at approximately 150 pm from the surface in the
epithelium (51). There have been many other attempts to locate the permeability barrier
using different stripping techniques which involve removal of successive layers of
mucosa by using adhesive tapes (52, 53) or by use of dermatome (50), The main
drawback of such harsh techniques is that they may cause trauma to the cell layers and
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falsely represent the permeability values. In view of the contradictory reports it is
important to verify and determine the role of epithelium and connective tissue of buccal
mucosa as permeability barrier for the diffusion of compounds.
Various permeation studies of drugs are carried out using varying thicknesses of
porcine buccal mucosa - 500pm (51, 54-58), 500-600pm (59-64), 600-800pm (46, 65,
66), 770±280pm (24), 736±110pm (67) and 1000pm (68-70). Since, it is assumed that
only the upper one third region of the epithelium acts as a permeability barrier, little
attention is paid on the exact thickness of the tissue used in the permeation studies. This
variation in mucosal thickness leads to a high variability in the permeability data and it
often becomes difficult to compare such data from different reports. The porcine buccal
epithelium is about 250 pm thick and lies on a dense irregular connective tissue known as
lamina propria (71). The thickness of connective tissue can vary anywhere from 150 to
450 pm. Hence the full thickness buccal mucosa in a porcine model may range anywhere
from 400pm to 700 pm. When studies are conducted with tissues of increasing
thickness, it corresponds only to an increase in connective tissue portion, and not the
epithelium. In the current research, it was hypothesized that increase in the connective
tissue thickness decreases the permeability and increases the lag time of the diffusants as
they have to travel a longer path. As seen in Table 2.3, an increase in the mucosal
thickness by 100 pm significantly decreased the peimeability for all diffusants studied.
This indicates the importance of maintaining a uniform tissue thickness in all the mucosal
tissues while carrying out the permeation studies. Deviation in the mucosal thickness by
about 100 pm may introduce significant variability in the permeability data.
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According to Fick s law of diffusion the apparent permeability of a diffusant is
inversely proportional to the thickness of the membrane. When apparent permeability
was plotted against the reciprocal of mucosal thickness, a linear relationship was
observed suggesting that all the diffusants permeated by passive diffusion. The slope has
higher values for the lipophilic diffusants — buspirone and bupivacaine when compared to
antipyrine and caffeine (Figure 2.6), indicating that the connective tissue region acted as
a stronger barrier to more lipophilic diffusants than to the relatively hydrophilic
diffusants. This effect was also observed when permeation studies were carried out in
epithelium and full-thickness mucosa with estradiol and caffeine by Nicolazzo et al and
acebutolol and propranolol by Vries et al (49, 72, 73).
The lag time for the diffusants to achieve a steady state flux increased
significantly with an increase in the total mucosal thickness by 100 pm (Table 2.8). Also
as seen in Table 2.8, for a mucosal thickness of 250 pm which corresponds to the
epithelium, the lag time for the lipophilic diffusants was much lower than hydrophilic
diffusants. The lag time increased drastically for the lipophilic diffusants at a higher
mucosal thickness (400 pm) which corresponded to the introduction of connective tissue
region in the mucosa. However, there was a gradual increase in the lag time for the
hydrophilic diffusants - antipyrine and caffeine with an increase in the connective tissue
thickness. This indicates that the barrier nature of the epithelium is less strong for
lipophilic diffusants when compared to the hydrophilic diffusants. On the other hand, the
connective tissue region poses as a stronger barrier for the lipophilic diffusants when
compared to the hydrophilic diffusants. The hydrophilic diffusants preferentially
transport across the buccal mucosa via the hydrophilic intercellular space which is more
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prominently present in the connective tissue region of the buccal mucosa. Because of the
hydrophilic nature of the connective tissue, it may only offer smaller resistance to
penetration of hydrophilic molecules when compared to lipophilic molecules. The
epithelium on the other hand has relatively lesser hydrophilic intercellular spaces and
hence acts as a stronger barrier to penetration of hydrophilic diffusant molecules. Hence
such diffusants show lower apparent permeability values and a longer lag time (10). The
lipophilic diffusants on the other hand preferentially transverse across the lipophilic cell
membrane by transcellular route (trans - across). This route has a greater surface area in
the epithelial region and the path length for transcellular route is relatively short, hence
buspirone and bupivacaine showed a high permeability with a low lag-time. The slope of
the linear relationship between the diffusant permeability and the inverse of thickness
was much higher for buspirone and bupivacaine than the slope of line observed for
antipyrine and caffeine.
To investigate this aspect of analysis in more detail, a bilayered membrane model
was used. The model helped determine the permeability and diffusion coefficient values
of the epithelium and the connective tissue regions of the porcine buccal mucosa. The
data so far suggested that the porcine buccal mucosa is not a homogeneous membrane,
but consists of two layers which may have different diffusivity and permeability
characteristics. To understand this heterogeneity and precise nature of the permeability
barrier, the relative contribution of the barrier properties offered by the epithelium and
the connective tissue was determined by using the bilayer model equation wherein it was
proposed that the epithelium and the connective tissue form a resistance model in series
(21). This bilayer diffusion model (Equation 9) helped to understand the precise barrier
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nature of the two regions

the epithelial region and the connective tissue region of the

buccal mucosa. The major assumption in the derivation of the bilayer diffusion equations
of permeability and diffusion coefficients was that the partition coefficient or the ratio of
the concentrations of the diffusants at the interface is equal to the ratio of the diffusant
concentrations in the epithelium and connective tissue. This assumption was based on
the understanding that the surfaces of both the connective tissue and the epithelial cells
are mainly composed of lipid bilayers having similar lipid composition.

Hence the

partitioning of the diffusant between the aqueous buffer phase and the lipid membrane
would be similar for both the epithelial and connective tissue cell membranes. For the
barrier membranes studied, this equation is justified in so far as there is agreement
between theory and experiment. The permeability barrier offered by static diffusion layer
was considered to be negligible and avoided in the series equation since it would be equal
for all thicknesses of the mucosa and hence would not affect the relative permeability of
the diffusants across membranes of varying thicknesses.
Contrary to the popular belief, the connective tissue presented a formidable
permeability barrier as the resistance offered by the connective tissue increased with
increasing mucosal thickness (Figures 2.7, 2.8, 2.9 & 2.10).

For a total mucosal

thickness of about 500 pm which comprised of the epithelium and the connective tissue
region having equal thicknesses of about 250 pm, the epithelium acted as a major barrier
in the case of all diffusants. From the plot of apparent permeability vs. reciprocal of
mucosal thickness, it may not always be immediately apparent that the buccal mucosa is
a heterogeneous permeability barrier. Clearly the Tables 2.4, 2,5, 2.6 and 2.7 indicate
that there is an appreciable range of the mucosal thickness (250 - 500pm) over which the
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epithelium acts as a major permeability barrier when compared to the connective tissue.
This data clearly indicates that the relative contribution of the connective tissue region as
a permeability barrier significantly increases with increasing mucosal tissue thickness.
The histological tissue specimens show that the epithelial thickness remained fairly
constant, while the connective tissue thickness increased with an increase in total
mucosal thickness. This indicates that the permeability characteristics of the various
diffusants change due to the change in the thickness of the connective tissue region only.
These findings are in agreement with observations of Xiang et al (21) that the epithelium
of buccal mucosa acted as a major barrier to the permeation of dideoxycytidine.
However, it is important to know the diffusion characteristics of the two barrier
membranes — the epithelium and the connective tissue region for a better understanding
of the barrier nature. The decrease in the permeability of the model diffusants with
increasing mucosal thickness does not provide enough information about the diffusion
characteristic of the membrane. In case of a homogeneous barrier membrane, the
diffusion coefficient would remain constant in spite of increasing mucosal thickness. The
diffusion coefficient would however change if the membrane is heterogeneous or
composed of two or more barrier membranes. The diffusion coefficient ot the epithelium
was determined from the experimental lag time and permeability values. Using the lag
time equation for a bilayered membrane system (Equation 14), the diffusion coefficient
of the connective tissue region was determined at different mucosal thicknesses. The
diffusion coefficient of the epithelium was found to be significantly lower than the
diffusion coefficient of the connective tissue region at all given thicknesses and for all
diffusants irrespective of their lipophilicity. However, when the diffusion coefficients of
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the epithelia were related to the diffusant's lipophilicity, the epithelium was found to be
more permeable for a lipophilic diffusant such as buspirone and bupivacaine than for
hydrophilic diffusants like antipyrine and caffeine. On the other hand the diffusion
coefficient of the connective tissue region did not show such a trend with the diffusant's
lipophilicity. This may be explained by the fact that the diffusion coefficient of the
connective tissue region was not obtained experimentally, but was calculated from the lag
time equation of a bilayered membrane model. This equation may be insufficient to take
into account the extent of heterogeneity of the connective tissue and the contribution of
the aqueous pores present in the connective tissue region which may affect the diffusivity
of diffusants of varying lipophilicities.

2.6

Conclusion

The barrier nature of the buccal mucosa increased with an increase in tissue
thickness for all diffusants irrespective of their physico-chemical properties. The buccal
mucosa is a heterogeneous membrane comprising of two regions - the epithelium and the
connective tissue each contributing in different proportions towards the barrier properties.
The epithelium acts as a major permeability barrier to diffusion of molecules, however
the relative contribution of the connective tissue region in barrier function increases with
increasing tissue thickness.

The epithelium acts as a stronger barrier up to a total

mucosal thickness of 500 pm for all diffusants irrespective of their physico-chemical
characteristics. The connective tissue acts as a major barrier at a mucosal thickness of
700 pm for all the four diffusants studied. The epithelium acts as a greater barrier to
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diffusion of hydrophilic diffusants when compared to the relatively more lipophilic
diffusants.
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CHAPTER 3
THE INFLUENCE OF BIOLOGICAL AND EXPERIMENTAL VARIABLES ON
THE IN VITRO TRANSBUCCAL PERMEATION

3.1

Introduction

The oral route is the most commonly employed route for administration of
medications. Due to the limitations associated with this route, potential use of other
routes is being investigated for drug administration. Drug delivery via the buccal (cheek)
mucosa possesses many advantages over the other routes and is rapidly emerging as a
novel route of delivery for such drugs. In buccal delivery, an adhesive patch or a tablet
containing the drug is placed in the buccal pouch which allows for absorption of the
active drug molecule across the buccal mucosa and into the blood circulation without
degradation by liver. Buccal mucosa appears to be better in terms of permeability,
surface area, compliance etc when compared to the other mucosal and transdermal routes
of delivery. Frequent exposure to food materials and rapid cell turnover make the buccal
mucosa more resistant to tissue damage and irritation compared to other mucosal routes
of administration. Hence, buccal route of drug delivery is ideal for drugs which undergo
extensive degradation in stomach and liver.
In vitro permeation studies have certain advantages over in vivo permeation
studies. Since extensive testing is essential in drug and drug product development, most
of the permeation studies are conducted

vitro using porcine tissue to assess its potential
in
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as a route for drug delivery. Porcine buccal mucosa has been found to be closest in
structure and permeability properties to human buccal mucosa (74, 75).
It serves as an excellent model to study mechanism of drug transport across
buccal mucosa. The permeation assembly can be easily setup using different types of
diffusion apparatus. Experimental conditions such as temperature, pH, osmolarity can be
controlled which makes it possible to single out one factor that is responsible for
variation.

Tissue is isolated from the whole animal which restricts the number of

variables that need to be controlled. The cost for conducting in vitro studies is lower than
in vivo studies since only a small piece of dissected buccal mucosa is used. Sample
analysis is easier because the receiver side is buffer solution rather than blood sample
from in vivo studies. Hence sample purification and preparation before analysis is
unnecessary.

Despite these advantages, there are limitations and problems associated

with in vitro assessment.
There is a significant variation in the results of permeation experiments across the
biological membrane. In permeation studies, it has been observed that the permeability
of a diffusant is not always the same across the porcine buccal membrane. For example
the permeability of 2 ,3 -dideoxycytidine in the porcine buccal mucosa has been reported
to be (1.75 ± 0.74) * 10"7 cm/s by Xiang et. al. and (4.09 ± 0.37) * 10"6 cm/s by Shojaei
et. al (21, 22). Hence it can be observed that the inter-lab variation in the permeability
values was more than twenty times. In such experiments the coefficient of variation is
often between 20 and 50%, and one would occasionally find C.V. as high as 80% or
more. The relatively large C.V. observed in buccal permeation experiment is mostly due
to 'biological variation' or the lack of reproducibility in living animal and use of varying
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experimental conditions used during such studies. On the other hand, the variability iin
chemical, enzymatic and instrumental analyses of compounds is usually very low and can
be avoided if the instrument is sensitive and proper care is taken while handling the drug
compounds. It is important to determine the different variables that are responsible for
such a high variation in the permeability experiments.

Once these variables are

determined, they can be avoided or minimized. In cases where it is unavoidable, the
permeability data can be normalized with that particular variable leading to a data which
has significantly lower standard deviation and coefficient of variation.
The biological characteristic which may cause variability in the permeability
values can be use of different mucosal sites in the permeation studies. The different
experimental conditions which may be likely to contribute to the variance in tissue
permeability are varying tissue storage conditions and different ways of tissue processing
before permeation studies. Some of these variables may also affect the tissue integrity
and hence the permeability of the concerned drug molecule. So far, the effects of these
variables have not been explored well enough in the transbuccal permeation studies.
There is a strong need to optimize the in vitro permeability conditions in order to obtain
permeability values which are more reliable and consistent. It is thus necessary to study
the various variables that may cause variation in the permeability of diffusant molecules.
These variables once determined can be avoided or minimized, where possible, so that
we get an experimental data which is precise and accurate and true representation of the
in vivo situation. The objective of this research is to evaluate the influence of mucosal
region and storage conditions that cause variability in the

vitro permeation of drugs

across the porcine buccal mucosa. We also compared the two most common methods of
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buccal tissue preparation

the surgical method and the heat separation method and their

effect on the tissue integrity and permeability.

3.2
3.2.1

Materials and Methods

Materials

Buspirone, bupivacaine, antipyrine and caffeine were obtained from SigmaAldrich, (St. Louis, MO, USA) and were used as model compounds since they have
different lipophilicities and physicochemical properties which are summarized in Table 1.
Tissue integrity was assessed by FD-20 [fluorescein isothiocyanate (FITC) - labeled
dextran of molecular weight 20,000 daltons] which is an established integrity marker in
buccal mucosa. Acetonitrile and methanol were obtained from VWR and were of HPLC
grade.

3.2.2

Tissue Preparation

Buccal mucosa was obtained from freshly sacrificed pigs of a local ranch (Long
Ranch Inc.). The mucosa was transported to the laboratory in isotonic phosphate buffer
(pH 7.4) and used within two hours of animal sacrifice. The majority of underlying
connective tissue was removed with the help of a scalpel blade and then the remaining
buccal mucosa was carefully trimmed with the help of surgical scissors to uniform
thicknesses of about 500 pm. The thickness of the tissues was measured with the help of
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a digital screw gauge and recorded. This helped to minimize variations between tissue
specimens.

3.2.3

Permeation Studies

The buccal mucosa was mounted on the vertical Franz diffusion cells in such a way that
the epithelium faced the donor chamber and the connective tissue region faced the
receiver chamber. A constant temperature of 37 °C was maintained throughout the
experiment in both the receiver and donor chambers to mimic the in vivo environment.
This was accomplished by mounting the diffusion assembly setup in a 37 °C walk-in
incubator room. The tissues were allowed to equilibrate with buffer for fifteen minutes
before commencement of the drug permeability experiment. The permeability
experiments were carried out using phosphate buffered saline (PBS) with pH 7.4 in the
receiver chamber and known concentrations of drug solutions at pH 6.8 in the donor
chamber to mimic the in vivo physiological pH conditions (45). Permeation studies were
carried out for up to four hours and 1 mL samples were withdrawn from the receiver
chamber at every thirty minutes. The receiver chamber was replaced with fresh buffer
solution (pH 7.4) of equal volume. All experiments were conducted in triplicates.

3.2.4

Effect of Mucosal Region
Porcine buccal mucosa was carefully isolated from the rest of the connective

tissue by scalpel/blade. The mucosa was then be sliced from the two different sites of
buccal region; viz.; the cheek region and the region behind the lip (Figure 3.1). This
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mucosa was then trimmed to a uniform thickness of about 500 pm using surgical scissors.
The processing of the tissues was completed within two hours of animal slaughter and
then the tissues were mounted on the diffusion cells for permeation studies.

3.2.5

Effect of Storage
Once the porcine buccal mucosa was trimmed to 500 pm thickness using surgical

scissors, it was stored in the following conditions:
1.

Storage in phosphate buffered saline (pH 7.4) for 6 hrs, 24 hrs and 48 hrs
in refrigerator at 4°C

2.

Storage in Kreb's bicarbonate ringer (pH 7.4) for 6 hrs, 24 hrs and 48 hrs
in refrigerator at 4° C

3.

Storage in dry form wrapped in aluminum foil for 6 hrs, 24 hrs and 48 hrs
in freezer at -20° C

4.

Storage in phosphate buffered saline (pH 7.4) for 6 hrs, 24 hrs and 48 hrs
in refrigerator at -20° C

5.

Cryoprotection: A 20% glycerol in isotonic saline solution was used as
cryoprotectant as described below.

The buccal tissues after being trimmed to a uniform thickness of 500 pm, were
immersed in the cryoprotectant solution tor 30 minutes so that the solution permeates into
the tissue. The tissues were then wrapped in aluminum foil and to minimize moisture
contact, they were placed in a dessicator. Alternatively the tissues were also frozen in the
cryo-protectant solution without drying them out. All the tissues were frozen for three
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Cheek region

Figure 3.1 Schematic of the entire region of the porcine buccal mucosa
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days at 20 C. Prior to conducting the diffusion experiments, the tissues were thawed to
room temperature to minimize the damage as much as possible. These thawed tissues
were immersed m freshly prepared phosphate buffered saline (pH 7.4) and mounted on
orbital shaker for 30 minutes, to remove the residual cryoprotective agent from the
tissues.
All the stored tissues were equilibrated with freshly prepared phosphate buffered
saline (pH 7.4) at room temperature before mounting them on the Franz diffusion cells.
Diffusion experiments with the three model drugs were conducted to observe at what
time period of storage the tissues showed higher permeability when compared to fresh
tissues. Tissue integrity studies using FD-20 were conducted as described below.

3.2.6

Effect of Heat Separation of Buccal Epithelium
Porcine buccal mucosa was carefully isolated from the rest of the connective

tissue by scalpel/blade. The mucosa was trimmed to a uniform thickness (—250 pm) until
the connective tissue was completely removed using surgical scissors. For processing of
heat separated epithelium, the mucosal tissues were dipped in saline solution (0.9%
NaCl) warmed at 60 °C for approximately one minute. Then the connective tissue was
peeled off from the mucosa to obtain the heat-separated epithelium. 1 he processing of
the tissues was completed within two hours of animal slaughter and then the epithelia
were mounted on the Franz diffusion cells for permeation studies. Tissue integrity
studies using FD-20 were conducted as described below.
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3.2.7

Tissue Integrity Studies
Fluorescien isothiocyanate labeled dextran of molecular weight 20,000 daltons

(FD-20) has been established as an integrity marker for porcine buccal mucosa (56, 72,
73). To test whether the buccal tissues remain integral after various storage conditions
and different processing methods of the buccal epithelia, permeation studies were
conducted using FD-20 at 100 pg/mL concentration. A significantly higher permeation
of the marker with respect to permeation in the control tissue indicates loss of integrity.
Samples from receiver chamber were collected every 30 minutes for 4 hours. FD-20
samples were quantified using a Shimadzu spectrofluorimeter. An excitation wavelength
of 498 nm and emission wavelength of 518 nm was used to quantify FD-20 on the
spectrofluorimeter. All the permeation experiments were conducted in triplicates.

3.2.8

Histological Examination
The histological changes in the buccal tissues of differing mucosal regions,

storage conditions and tissue processing methods were evaluated by sectioning them
carefully and fixing in vials containing 10% buffered formalin for 1 day at room
temperature. An optimized procedure was adapted for histological studies using the
paraffin technique. Tissue samples were successively dehydrated with increasing series
of ethanol concentrations - 30%, 50%, 70% and absolute alcohol. This was followed by
embedding in xylene and finally in paraffin. Paraffin cubes were sliced into thin slices of
5 pM thickness using a microtome (Model 820, American Optical Co., Buffalo, NY) and
then stained with Harris Hematoxylin and Eosin Y Stam. The stained slides were
examined under a Nikon Eclipse E800 light microscope with planfluor objective lenses
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(Nikon, Inc., Melville, NY). Two microscope slides per tissue sample were prepared and
examined. An Optronics DEI-750 three-chip CCD camera (Optronics Engineering,
Goleta, CA) was used to capture images. Images were processed by Image-Pro Plus
software (Media Cybernetics, Silver Spring, MD).

3.3 Results
3.3.1

Effect of Mucosal Region
Permeability of all the model permeants showed significantly higher permeability

in the region behind the lips in comparison to the cheek region (Table 3.1). This was true
even though both the regions constitute the same buccal mucosa.
This difference in permeability between the two regions was due to different
thicknesses of the epithelium. It was observed that the thickness of epithelium in the
region behind the lip was about 170-200 pm where as the thickness of epithelium in the
cheek region was 250-280pm. As can be seen in Table 3.2, when permeability
experiments were conducted in the epithelia from these two different regions, the
epithelium from region behind the lip showed significantly higher permeability than the
epithelium from the cheek region.
It can be also seen in the histological tissue specimens that the thickness of
epithelium is greater in the cheek region when compared to that in the region behind the
lip (Figure 3.2). Both the images were taken at same magnification (125X). The arrows
point out to the epithelial and connective tissue regions in both the figures.

73

CD

O
$
03
O

in
r-

NO
r-

-H
oc

-H
in

o

o

<D
.S
NO
NO

o

a
<

-H
m-

nt"

O
-H
in
NO

>o•&
O
<D
.S

"3
O
c3
>
'cl
O
P3

rcn

cn

o

o

-H

-H
m
r3_

CTN
(N

*
o
CD

O
*OH

cn
O
PQ

ON
CN

<N
rn

O

o

-H
No
ON
cn

-H
*—H
CN
mi

T3
CD

td
c3
OH
(D
1/3
l
"S
CD

X

OH

44

CD
CD

43

CD

£

O

PH
CD

75

T3
O
• ^H
43
D
PQ

m
II
O
m

o
o

V
Cu
cn
D
"E5
• SH
-3
o

I
1

Figure 3.2 Light microscopic view of transverse section of buccal mucosa from a) cheek
region and b) behind-lip region
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3.3.2

Effect of Storage Conditions
The porcine buccal mucosae were stored in various conditions for varying time

periods. The permeability of all model permeants increased significantly when the
tissues were frozen m either dry form wrapped in aluminum foil or in PBS buffer at -20
C for 6 hours. The permeability and the integrity of the buccal mucosa was also affected
when it was stored in Krebs bicarbonate ringer (KBR) for 48 hours or when it was stored
in Phosphate buffered saline (PBS) for 24 hours at pH 7.4 in refrigerator at 4 °C.
Cryoprotection with 20% glycerin in isotonic saline also did not help maintain the
integrity and permeability characteristics of the porcine buccal mucosa. In both the
cases: a) tissues pretreated with the cryoprotectant and wrapped in dry form in aluminum
foil or b) tissues immersed in the cryoprotectant solution and frozen, the tissue integrity
was lost along with an increase in permeability of the permeants. The integrity and the
tissue permeability characteristics were only maintained when the buccal mucosae were
stored either in PBS at 4 °C for 6 hours or in KBR at 4 °C for 24 hours (1 able 3.3). This
shows that KBR maintained the buccal tissue integrity for a longer period than PBS. For
reliable evaluation of in vitro permeability, use of fresh buccal tissues was tound to be the
best. If preservation is absolutely necessary, the best media for this purpose would be
KBR stored at 4 °C for up to 24 hours.
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Table 3.3 Effect of various storage conditions on the permeability of diffusants

Storage

Antipyrine

Buspirone

Caffeine

Fresh

(3.15±0.5) x 10"6

(1.54±0.04) x 10"5

(6.13 ± 0.75) x 10"6

6hrs, PBS, 4°C

(2.8 ± 0.4) x 10"6

(1.69 ± 0.15) x 10"5

(5.98 ± 1.23) x 10-6

24 hrs, PBS, 4°C

(4.51 ± 0.4) x 10"6*

24 hrs, KBR, 4°C

(4.39 ± 1.25) x 10'6

48 hrs, KBR, 4°C

(8.81 ±2) x 10"6*

(2.13 ± 0.12) x 10"5* (8.48 ± 1.23) x 10"6*
(1.63 ± 0.13) x 10"5

(6.25 ±0.33) x 10"6

(1.89 ± 0.23) x 10'5* (7.46 ± 0.47) x 10~6*

6 hrs, wrapped dry,
(7.73 ± 0.3) x 10"6*

(5.87 ± 0.06) x 10"6*

(2.53 ± 0.08) x 10~5*

(7.72 ± 0.94) x 10"6*

(4.53 ± 0.08) x 10"5* (1.05 ± 0.05) x 10"5 *

(8.36 ± 1.02) x 10"6 *

(5.31 ±0.08) x 10-5* (1.38 ± 0.16) x 10-5 *

-20°C
48 hours, cryogenic,
wrapped dry, -20°C
48 hours, cryogenic,
in glycerin, -20°C

( * indicates p < 0.05) (n-3)
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Figure 3.3 shows the cumulative amount of FD-20 permeated after 4 hours in
buccal tissues stored in different conditions. The donor concentration of FD-20 was
lOOpg/mL. Permeation of more than 0.1% of the integrity marker in the receiver
chamber over 4 hours indicated a loss of tissue integrity (73). By comparing with the
FD-20 permeation in fresh mucosal tissue, it can be seen that the tissue integrity was
maintained when the tissues were stored in PBS for 6 hours or in KBR for 24 hours at 4
°C. All other storage conditions lead to a loss of integrity.
Figures 3.4 to 3.11 show the light microscopic view of buccal mucosa obtained
after treatment in various storage conditions. The tissue specimens with 6 hour storage in
PBS (Figure 3.7) and 24 hr storage in KBR at 4°C (Figure 3.5) showed that the basal
lamina remained intact and no nucleated cell leakage was found. But in case of tissues
stored for longer period that is stored for 24 hours in PBS (Figure 3.8) or 48 hours in
KBR at 4°C (Figure 3.6), a visible damage in the superficial layers of epithelium can be
seen along with the disruption of basal lamina. Similar damage was observed with
buccal mucosa frozen at -20°C for 6 hours (Figure 3.9). In both cases, where tissues
pretreated with cryoprotectant and frozen in aluminum foil (Figure j.10) or tissues
immersed in cryoprotectant and frozen at -20°C (Figure 3.11) showed visible damage in
the epithelium, basal lamina and connective tissue region. Highest damage was seen in
these two tissue specimens. These data confirms the conclusion that the tissue viability
was maintained for longer period with KBR more than any other buffer and storage
condition. Hence tissues stored in KBR retain integrity longer and is recommended for
storage of the tissues, if they are to be used the next day.
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Storage Conditions

Figure 3.3 FD-20 permeation data for tissues stored in different conditions A - fresh
tissue (control); B - PBS, 6 hrs, 4°C; C - PBS, 24 hrs, 4°C; D - KBR, 24hrs, 4°C ; E KBR, 48hrs, 4°C; F - dry, 6hrs, -20°C ; G - dry and pretreated with glycerin, 48 hours, 20°C ; H - in glycerin, 48 hours, -20°C

Figure 3.6 Light microscopic view of buccal mucosa refrigerated tor 48 hours in KBR
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Figure 3.9 Light microscopic view of buccal mucosa frozen for 6 hours at -20 C
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Figure 3.10 Light microscopic view of buccal mucosa frozen for 48 hours at -20 C after
treatment with a cryogenic agent
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Figure 3.11 Light microscopic view of buccal mucosa frozen for 48 hours at -20° C
which was immersed in a cryogenic agent

3.3.3

Effect of Heat Separation of Buccal Epithelium
To assess whether heat separation of buccal epithelium has any harmful effects on

the integrity and permeability characteristics of the epithelium, permeability of model
compounds were compared using epithelia prepared by heat separation method and the
surgical isolation method. The permeation profiles of the four diffusants looked similar
for both heat separated epithelium and surgically removed epithelium (Figures 3.12, 3.13,
3.14 and 3.15). The permeability of the two epithelia did not change with change in the
tissue processing method (Table 3.4). This was true in case of the four diffusants which
had differing lipophilicities and pKa. The thickness of both the epithelia was
approximately same.
The tissue integrity was also studied in both the heat separated epithelium and the
surgically removed epithelium by conducting FD-20 marker permeation studies. An FD20 permeation of more than 0.1% of the initial donor concentration indicates loss ol
integrity (73). As can be seen from Figure 3.16, the tissue integrity was maintained even
after heat treatment since the amount of FD-20 permeated in heat separated epithelium
was not statistically different than that in the surgically removed epithelium and was less
than 0.1% of the donor concentration. The standard deviation in the surgically removed
epithelium was higher than that in heat separated epithelium due to changes in thickness
or cuts during the tissue preparation.
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Figure 3.12 Cumulative amount permeated vs. time profile for buspirone permeation
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T i m e (hours)
Figure 3.13 Cumulative amount permeated vs. time profile^for bupivacame permeation
across heat separated and surgically removed epithelium (n )
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Time (hours)
Figure 3.14 Cumulative amount permeated vs. time profile for antipynne permeation
across heat separated and surgically removed epithelium (n-3)

Figure 3.15 Cumulative amount permeated vs. time profile for caffeine permeation
across heat separated and surgically removed epithelium (n 3)
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Figure 3.17 shows the histology of the epithelium prepared by surgical removal
and Figure 3.18 shows the histology of heat separated epithelium (HSE). Basal lamina
was found to be intact in epithelium prepared by both the methods without any visible
damage. In case of surgically removed epithelium, there is a remnant connective tissue
observed as it was difficult to remove the connective tissue completely. However in case
of heat separated epithelium, it was seen that the connective tissue is completely removed
and the epithelium remained along with intact basal lamina. The vacuoles were absent in
epithelia prepared by heat separation, but this did not cause any adverse effect on the
tissue integrity and permeability characteristics.
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3.4 Discussion

3.4.1

Effect of Mucosal Region
While conducting permeation experiments, less attention is paid to which buccal

tissue area is used in the study with a few exceptions. Veuillez et al used the nonkeratinized buccal mucosa from the same region i.e. from the posterior angle of the
mouth to maintain reproducibility in tissue samples (70). One of the contributors to the
high variations in the buccal permeability of the molecules may be region of the mucosa
used in the experiments. Such variations in the permeability data of the same difiusant
using different mucosal sites may arise due to the regional variations in the thickness of
epithelium of the buccal tissue. Hence, an investigation was conducted to observe any
variation in the permeability value that might arise if the buccal tissue is used trom two
different regions: the middle cheek region, and the terminal region near lips as shown in
the Figure 3.1.
Change in the thickness of epithelium significantly contributes to a change in the
permeability values. Some researchers have shown that the buccal epithelium is a greater
permeability barrier than other oral epithelia due to its greater epithelial thickness, which
may be three to five times higher than that of the other non-keratinized epithelia (46).
However differences in the permeability and thicknesses in the different regions of buccal
mucosa have not been reported yet. In this research, it is hypothesized that the variation
in the flux may be attributed to different thicknesses of the epithelia obtained from
different buccal regions. Different specimens of buccal mucosae from different regions
may have different epithelial thicknesses which may vary from 150 microns to 250
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microns. This may result in variation of steady state flux of the diffusant. Since the
tissue regions are from the same buccal mucosa, other probable causes of biological
variation may be ruled out such as the differences in the number or volume density of
membrane coating granules in the region behind the lip and the cheek region, or
differences in the nature of the intercellular barrier material (76).
Permeability data of the four diffusants clearly demonstrated that the permeability
in the region behind the lip was significantly higher than that of the cheek region. It has
already been shown in this work that epithelium acts as a major permeability barrier.
Measurement of the epithelial thickness in the two different mucosal sites showed that
the thickness of the cheek was higher than the thickness of the region behind lip even
though both mucosal sites were of the buccal region and the same animal. Histological
studies of the two mucosal specimens also showed that the epithelium in the region
behind the lip contained fewer cell layers than in the epithelium of the cheek mucosa.
Hence change in the site of mucosal excision in the porcine buccal mucosa may be a
cause of variation in the permeability data obtained in in vitro transbuccal permeation
studies.

3.4.2

Effect of Tissue Storage
Different research laboratories tend to store the buccal tissues in different ways

prior to conducting the

vitro transbuccal permeation
in
studies. The obvious reason for

• 1- •, i ^ucmmtv of fresh buccal tissues. Le Brun et al

such a storage requirement is limited availab

y

. .
• pnq /„pr 7 4) for several days and found that the
preserved the buccal tissue in PBS (pri ' • )
permeability of propranolol decreased over

mra 0tnraap neriod (77). Other investigators
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however, have a shown an increase in permeability after storage in aqueous buffers (5).
De Vries et al stored the buccal mucosa at room temperature up to 24 hours prior to
conducting the experiments (78). Galey et al stored the dog buccal tissues in balanced
salt solution at 4 °C for up to five weeks prior to conducting permeation studies and did
not find any change in its permeability characteristics (79). Dowty et al stored the buccal
tissues in ice cold saline before conducting permeation studies (30). Le Brun et al stored
the tissues for several hours in PBS prior to permeation studies (77). Imbert and
Cullander found that the buccal tissue viability was lost after 8 hours when stored in PBS
at 34 °C and it was maintained in KBR after 20 hrs at room temperature (80). Lee et al
showed that the [3H] water permeability did not change when the porcine buccal tissue
was stored at 4 °C intact in the pig head. However the permeability increased
significantly when the buccal tissue was frozen at -20 °C for 24 hrs (81). Most of the
laboratories store the buccal tissues at -20 °C to -30 °C and even -90 C before
conducting in vitro permeability or mucoadhesion studies (23, 24, 32, 82-87). They
claim that no significant differences have been observed between the mucoadhesive
strength of freshly excised mucosa and mucosa frozen at -20 °C (25, 82, 83, 88, 89).
Nicolazzo et al stored the buccal tissues in freezer at -20 °C for a month and found that
there was no difference in permeability of caffeine and estradiol when compared to fresh
tissues. The investigators also reported that there was no change in the integrity of frozen
tissue based upon the FD-20 permeation data; however they observed a significant
damage to the frozen tissue in histological examination (73). Consuelo et al wrapped the
, rbuccal mucosa in aluminum foil and froze

-90 °C for three weeks and found that

• rwcnvl nermeability when compare with fresh
there was no significant change in fenta y p
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mucosa (24). Similar results were reported with other compounds where the permeability
did not alter after freezing the buccal mucosa at -20 °C (90, 91). Veuillez et al stored the
tissues at -20 C for no more than 4 weeks before conducting permeation studies (32).
Lesch et al snap-froze the tissues in liquid nitrogen and then stored the buccal tissues in
air tight containers in a freezer at -85 °C for six months before use. They did not observe
any significant change in permeability to water when compared to fresh tissues in both
human as well as porcine buccal mucosa (92). Microscopic examination of the tissue
also did not show any major damage.
It is believed that a major disadvantage of such storage is the loss of integrity and
permeability characteristics of the tissue over time. These buccal tissues are stored in
refrigerator (4 °C) or freezer (-20 °C to -80 °C) in different kinds of buffers or simply
wrapped in aluminum foil in dry form for different time intervals before conducting
permeation studies. The steady state flux values obtained from using these stored tissues
along with fresh tissues may lead to a high variability and often peimeability data which
may be far from the true permeability. Compromise in the integrity of the aged tissue
would result in higher and false permeability values and a subsequent error associated
with a set of drug permeability data from both fresh and aged tissue would be larger.
There is a necessity to determine the influence of these storage conditions on the
permeability of various drug molecules which will help in gaming a clearer
understanding on the relationship between tissue integrity and permeability. Such
experiments will also help to optimize the storage condition and time for storage of a
buccal tissue, which can then be used for conducting permeation studies along with the
fresh tissues without a significant increase in coefficient of variation.
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Various methods have been used to assess the integrity of excised tissues used in
in vitro permeability experiments. Integrity markers are often used in in vitro
permeability experiments to ensure that the model membrane is intact, and that the
observed permeability profiles of model compounds are not a result of compromised
tissue integrity. An important component of this study, therefore, was to assess the
integrity ol the mucosal tissue with an integrity marker such as a high molecular weight
fluorescein isothiocyanate (FITC)-labeled dextran (20,000 daltons) also known as FD20.
FD20 was chosen as an appropriate marker of tissue integrity because a previous study
has revealed that passage of porcine buccal mucosa by FITC-dextran is restricted to a
molecular weight lower than 20 kDa (56, 58, 61). Therefore, appearance of FD20 in the
receptor chamber of the in vitro model would be indicative of compromised tissue
integrity. As shown in Figure 2, when compared to the fresh tissues, the permeability of
FD-20 was significantly higher in tissues stored in various conditions with the exception
of two conditions — tissues stored in PBS for 6 hours or in KBR for 24 hours in
refrigerator (4 °C). This indicated the maintenance of integrity in these tissues.
Tissue viability may decrease over storage time and so the steady-state profile
achieved in the

vitro experiment
in may be different from that observed in a fresh viable

tissue. Various methods have been used to assess the viability of excised tissues used in
in vitro permeability experiments. Enzymatic methods such as the MTT assay have been
used to evaluate t.ssue viability (73). However, Nicolazzo et al found inconsistency
between results from MTT assay and histological evaluation of frozen buccal mucosa.
j
•
Although histological studies showed a sig

Hamctse to the frozen mucosa, M n

d
+Uri+xr nf the enzvme tetrazolium reductase
assay failed to show cell death because the ac
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was not affected by the freezing process (73). This suggests that MTT assay cannot be
used as an indicator of tissue viability and hence histological evaluation is very important
in order to assess the viability of the porcine buccal mucosa. It has been reported that the
most meaningful method to assess tissue viability is the actual permeability experiment
itself, and if the drug permeability does not change during the time course of the
experiment, then the tissue is considered viable (76, 93). Hence the experiments were
more focused towards conducting the actual permeability assessments in three model
diffusants having varying lipophilicities.
In this research, it is hypothesized that the storage of the tissue at refrigeration or
at freezing temperatures will compromise the barrier properties of the tissue, and will
subsequently increase the drug permeability. Hence an investigation on ditlerent storage
conditions used by different labs in the buccal permeation studies was conducted. 1 he
duration for which a tissue remains integral and the permeability characteristics are
maintained was determined. The buccal tissues were stored in different storage
conditions such as tissue stored in dry form or in suitable isotonic buffers such as
phosphate buffered saline (PBS) or in Kreb s bicarbonate Ringer s (KBR) s
refrigerated condition at 4 °C or at -20°C. In both the buffers, isotonicity was
maintained. As seen from Table 3.3, the permeability characteristics of the buccal tissues
were maintained when they were stored for up to 6 hours in PB
permeability characteristics of the tissue were maintained for longer trme - 24 hours
when they were stored in KBR at 4 °C. The plausible reason for the tissue to remain
integral for longer time in Kreb's b.carbonate Ringer's solution (KBR) would be the
presence of glucose media in KBR which provides nutrition to the tissue.
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The second objective of this research was to investigate a suitable storage
condition for storing the tissues for longer periods of time without any compromise in
tissue integrity and maintaining similar permeability profiles as the fresh tissue. One
such technique which was investigated was storing the tissue with a cryoprotective agent.
There is no reported literature of buccal tissue being stored with a cryoprotective agent.
Although there is an interesting finding reported in case of skin where the skin membrane
was stored in a cryoprotective agent viz., glycerol at -20 °C and found that permeability
didn't change up to 60 days (94). In the current research, it was hypothesized that using a
cryoprotective agent for freezing the buccal tissues will minimize ice crystal formation
and subsequent damage to the layers of buccal membrane. This would increase the lite ol
the mucosal membrane and make it suitable to store for longer periods of time before
conducting the permeation studies, fiowever results obtained in the current studies
indicated that the cryoprotective agent - glycerol damaged the integrity of the buccal
tissues in 48 hours. Hence it would not be suitable to use a cryoprotective agent for
tissue storage in freezer.
A histological evaluation was also conducted to demonstrate any significant
morphological changes in buccal tissues stored in different conditions. The microscopic
examinations revealed similar trends as observed in the tissue permeability and integrity
studies, with the tissues refrigerated in PBS and KBR for 6 and 24 hours respectively
showing lesser damage in cellular layers as compared to tissues in other storage
conditions.
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3.4.3

Effect of Heat Separation of Buccal Epithelium
The connective tissue, like a stagnant layer, may significantly affect permeability

if the thickness of the connective tissue is sizable (72, 75). Therefore, successful removal
of connective tissue is essential to minimize variation between tissue specimens. Since
the procedure of removing connective tissue with surgical scissors is time consuming and
requires skill and patience, many researchers developed chemical (5, 49, 95), thermal
(49), enzymatic methods like use of collagenase (96-99) for teasing away the buccal
epithelium from the underlying connective tissue and mechanical separation with a
dermatome (54, 75) or other surgical instruments (73, 82). However, dermatome might
damage the tissue and render it rather fragile (5). Mechanical separation with a
dermatome might cut through the papillae (5), while surgical separation with scissors and
forceps are technically difficult and time-consuming. Also the tissue needs to be Irozen
prior to dermatomization and this may change the integrity and permeability
characteristics of the buccal mucosa. Some other methods utilize use of plastic adherent
tapes or EDTA for stripping (5, 77). In case of EDTA splitting, the tissues are incubated
for up to 50 minutes at 60°C in 20mM EDTA disodium salt in PBS (PH 7.4) (5, 77).
The epithelium is then peeled off from the connective tissue. It appears from these
experiments that these treatments may substantially alter the penneabilrty properties of
the buecal mucosa. Although Le Brun e, al have reported that there was no struc.ura,
damage to the bucca. mucosa alter EDTA treatment as seen under the light mtcroscope or

0771 other investigators have reported contrasting findings. In
with electron microscope (77), other inve g
,
pnTA which are used for removal of connective
fact, many chemical agents such as ED 1
trv pnhance drug absorption across the
tissue from the epithelium have been shown
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biological membrane (11, 50, 100). An enzymatre treatment method was used to separate
buccal epithelium from the connective tissue in hamster pouch tissue. In this method the
tissue was treated with 0.5% collagenase solution for 20 minutes (97). However, it
should be noted that the rate limiting barrier in hamster pouch is keratin layer. Hence
even though, collagenase did not affect the keratin layer, it is quite possible that such an
enzymatic treatment would affect the viable portion of the epithelium. In general, these
treatments of the tissue cannot guarantee the same permeation results because it is
unclear what microscopic changes in the tissues have occurred.
Often buccal permeation studies have been conducted using buccal epithelia after
heat treating the tissues in saline solution at 60°C for one minute (24, 101-103). The
histological examination shows that separation takes place at the basal layer without any
compromise in the epithelial integrity (24). Some laboratories also use the buccal tissues
from pigs which have undergone post mortem heat treatment in the slaughterhouse for
four minutes (72, 73). It has been shown that such a post mortem heat treatment does not
affect epithelial morphology or permeability (73). Some researchers even treat the buccal
mucosa a, higher temperature of 70 °C in saline solution (82, 83, 102). This helps in easy
removal of the connective tissue. In another study conducted by Chang et al, they
removed the epithelium from the connective tissue by holding a aluminum cylinder
heated at 60 °C close to the epithelial surface (87). In summary, therefor ,
separation approach adopted seems reasonable and appropriate. The use of higher
i
because of the possibility of the transitions in
temperatures may raise concerns, howeve ,
„ • mp ckin's stratum corneum
lipid stmcture and organization (as are known to occ
• n a buccal mucosa from dogs suggest that
(104). However, data from the literature using
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irreversible effects only occur above 68 °C (105). Hence heat separation at 60 °C would
be a safer temperature to carry separation of epithelium from the connective tissue.
Heat treatment is a less tedious and easier procedure for separation of epithelium
from the connective tissue. The heat treatment consists of immersing the tissue in saline
solution at 60 °C for one minute, and then carefully peeling off the connective tissue
from the epithelium. This is a relatively mild treatment and is believed not to harm the
lipid constitution and integrity of the buccal mucosa. It has been reported that the first
lipid transition in buccal mucosa occurs at approximately 70 °C (72, 106). Hence we can
safely assume that the intercellular lipids are not affected by this heat treatment.
The alternative tedious and time-consuming procedure for removal of connective
tissue is by use of surgical scissors. However, since these two methods were
considerably safe, it was essential to do a comparison and investigate any change in
permeability characteristics or integrity when these two different procedures are adopted.
The use of dermatome for the slicing of the tissue was avoided since it requires prior
freezing which may compromise the barrier properties of the epithelium as well as the
connective tissue region of the buccal mucosa. Through comparison of various
permeability, integrity and histologreal experiments on the tissues processed by either
hea, treatment or by surgical removal, it was determined that the hear treatment method is
as safe as the separation of epithelium by surgical scissors. The permeability of the

i ctv
model diffusants and the integrity marker

if) rlid not change significantly in tissues

processed using the two methods. I, was also a lo, easier and less rime consuming to
process the tissue by heat separation rather than by using surgical scissors. Also.,« was
flnvp

not possible to completely and uniformly re

108

the

connective tissue region using

surgical scissors as can be seen from the microscopic examination of the epithelium
obtained by surgical processing.

3.5

Conclusion

The permeability of the model diffusants is affected by the site of excision of the
buccal mucosa used in permeation studies. The region behind the lip has lower epithelial
thickness which results in a higher permeability of model diffusants when compared to
the middle- cheek region. From the results of experiments conducted on various storage
conditions employed, it was concluded that for the purposes of assessing drug
permeability in vitro, the appropriate storage time would be up to 24 hours in KBR at 4
°C as this would avoid artefacts in the permeability data. Heat separation of buccal
epithelium did not adversely affect the permeability and integrity characteristics of the
porcine buccal epithelium. While conducting in vitro permeability studies across porcine
buccal mucosa, it is highly recommended that fresh tissues are used and that the tissues
are excised from the same site of buccal region. It would be better to use heat separated
epithelta since complete removal of connective tissue is possible only with this
processing method without any compromise in tissue integrity and permeability
characteristics.
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CHAPTER FOUR
THE EFFECT OF EXPERIMENTAL TEMPERATURE ON THE IN VITRO
TRANSBUCCAL PERMEATION OF MODEL DIFFUSANTS

4.1

Introduction

The oral route is the most commonly employed route for administration of medications.
Due to the limitations associated with this route, potential use of other routes is being
investigated for drug administration. In buccal delivery, an adhesive patch or a tablet
containing the drug is placed in the buccal pouch which allows for absorption of the
active drug molecule across the buccal mucosa and into the blood circulation without
degradation by liver. Hence, buccal route of drug delivery is ideal for drugs which
undergo extensive degradation in stomach and liver. Drug delivery via the buccal mucosa
possesses many advantages over the other routes and is rapidly emerging as a novel route
of delivery for such drugs (93). Hence over the past few years, attention has been focused
on overcoming the problems associated with buccal drug delivery. One of the prime
concerns facing the buccal delivery is poor absorption when compared to the sublingual
route of drug delivery. The success of a buccal drug delivery system depends on the
ability of the drug to permeate the mucosal barrier in sufficient quantities to achieve its
desired therapeutic effect.

The buccal mucosa acts as a rate-limiting barrier to the

permeation of exogenous material across the tissue.

Transport across the buccal

epithelium is via passive diffusion; with no active transport processes present.
1in

Various strategies of permeation enhancement are being studied to increase the rate and
amount of absorption of drugs across buccal mucosa. Few among them are use of either
chemical (e.g. penetration enhancers, supersaturated systems) or physical methods (e.g.
ultrasound, iontophoresis, microneedles, etc.) to overcome the barrier properties.
However, it is essential that any method employed to decrease the barrier properties are
reversible, so that the long term protective nature of the mucosa is retained.
Chemical penetration enhancers are being extensively studied as a way to
improve delivery of drugs across buccal mucosa. However the major limitation of these
efficient permeation enhancers is the toxicity associated with their use.

Hence an

alternative means of enhancing permeation which is safe as well as effective needs to be
investigated. A possible method of accelerating the transport of drugs across the buccal
mucosa is to apply heat or deliver the drug by locally increasing the temperature in the
buccal region.
The effect of heat as a means of enhancing transdermal and transvaginal routes of
absorption has been well documented (43, 107-114), but its effect has never been fully
explored in buccal mucosa. This temperature effect can be exploited as a means of aiding
drug delivery across the buccal mucosa. Some investigators showed an approximately
doubling of transdermal flux with each 6-8 °C increase in temperature from 10 to 60 °C
(108, 115).
Thus, there has been relatively little investigation of the effect of temperature on
buccal permeation compared to other methods of penetration enhancement. It is essential
that the effect of temperature on penetrant molecule be well defined in order to
understand the mechanism of enhancement.
Ill

Most of the permeability assessment of various drugs across buccal mucosa is
conducted in vitro using porcine buccal tissue and an experimental diffusion assembly.
Porcine buccal mucosa has been found to be closest in structure and permeability
properties to human cheek(74, 75). It serves as an excellent model to conduct in vitro
permeation studies of various drugs. The temperature used in permeation studies can
have a significant impact on the permeability values of different drugs across the buccal
mucosa.

Different labs use different temperature conditions in their permeation

experiments. Some labs use room temperature, 25 °C (23, 28, 59, 92), some labs use 30
(79), others use 34 °C (54, 56, 58, 60, 61, 65) whereas most of the labs use physiological
temperature 37 °C (21, 29-31, 33, 37, 66, 67, 77, 116). Lesch et al justified using room
temperature for permeation studies saying that differences between body and ambient
temperature will have minor effects and the permeation of compounds occurs by simple
diffusion across the oral mucosa and is not affected by metabolic inhibitors (92). Some
labs use Franz diffusion cells with 37 °C in the receiver chamber and 22-24 °C in the
donor chamber (24, 32, 62, 63, 68-70, 82, 83, 101,117-119). The major shortcoming of
such an experimental setup for in vitro permeation studies across the buccal mucosa is
that it does no, mimic the in vivo condi,ton. Ideally, both the donor and receiver chamber
should be matntained a, a constant temperature of 37 »C to mirntc the in vivo
environment. Maintaining temperatures other than 37°C would also lead to a stgntfican,
change in Ore permeability data and it would be impractical to compare results from two
different labs or correlate

vitro and in vivo permeability
in data of these drugs. Hence, tt

would be interesting to investigate the impact of the experimental temperature used in the
,
k ;i ;t\- One mav anticipate an increase in the drug
permeation studies on the drug permeability. One may ant p
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permeability with an increase in experimental temperature, but to predict the kind of
relationship - whether it increases linearly or it increases exponentially with temperature
would be difficult unless actual experiments are conducted. It would also be interesting
to investigate whether this increase in permeability with elevated temperature is due to
the change in the barrier structure or decrease in integrity of the buccal mucosa. The
major advantage of this part of research would be its applicability to buccal drug
delivery. If it is observe that there is a significant increase in the permeability of the
buccal mucosa with just a small increment in temperature, then this finding can be
exploited in developing a buccal drug delivery system which utilizes this principle of
temperature increase. In that case, use of heat will be a safer alternative than the use of
hazardous and toxic penetration enhancers. However, the use of higher temperatures
(>45 °C) for a long period of time as employed in this study may cause patient
discomfort. For example, in case of certain transdermal formulations, bums (scalds) have
been shown to occur with the use of temperatures in excess of 60 °C for a short period
(120).

Hence a careful investigation into the effect of periodic increases in

physiologically acceptable temperature on transbuccal absorption and retention needs to
be done.
The objective

of

this work is, therefore, to evaluate the influence of temperature

on the permeation of compounds of differing lipophilieities across porcine buccal
mucosa. Buspirone, bupivacaine, antipyrine and caffeine with logD values of 2.8, 2.5,
0.39, and -0.07 respectively at a pH of 6.8 were chosen as model compounds in these
studies. These studies would also provide a basis for designing buccal drug delivery
systems that utilize increased temperature as mechanism of permeation enhancement.
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4.2

Theory

The temperature dependence of diffusant molecule across the buccal membrane
would most likely obey a relationship similar to the Arrhenius equation as given below
(121):
~EA

D T =D 0 x e R T

(16)

where Dx = the diffusion coefficient at a certain temperature (m /s)
Do = the theoretical maximum diffusion coefficient at infinite temperature (Kelvin),
arbitrary value (pre-exponential factor)
Ea = activation energy of diffusion (Joule/Mole)
R = the universal gas constant (83144 Joules/Mole*Kelvin)
T = the temperature of interest (Kelvin)
The activation energy is the measure of the energy expended against the cohesive forces
of the membrane in forming the gaps through which diffusion will occur.
We also know that.

D
T

T

X

K

(17)

h

where PT = permeability of the diffusant at the temperature of interest
K = partition coefficient of the diffusant
h = thickness of the membrane
Combining equations (16) and (17), we get
-

Dq x e
Pt=

E

A

RT

xK

(18)

h
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Assuming that the partition coefficient remains constant over the range of temperature
studied, we can say that
-l

PT

eT

(19)

Hence, it can be said that the permeability of diffusant increases exponentially
with temperature. In other words, if a plot of log of permeability vs. absolute temperature
is made, it will yield a linear relationship.
The slope of the Arrhenius plot which is proportional to the activation energy ( E a )
gives an indication of the energy level necessary for the penetrants to break restraining
bonds and diffuse, i.e. it provides a measure of the resistance to diffusion of the penetrant
to cross the buccal mucosa. In general, the value of the activation energy is a function
of both the diffusing molecule and the diffusion pathway (121).
The enhancement in permeability was calculated for every 7°C rise in the
temperature and it is given by ratio known as enhancement factor (EF). It is calculated
using the equation
Permeability at a higher temperature
Enhancement factor (EF) - permeabiiity at iower preceding temperature

4.3

4.3.1

Materials and Methods

Materials
Buspirone, bupivaeaine, an.ipyrine and eaffeine were obtained from Sigma-

Aldrich, (St. Louis, MO, USA). Acetonitrile and methanol were obtained from VWR and
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ere I IPIX grade. The four model compounds - buspirone, bupivacaine, antipyrine and
catleine were chosen for in vitro transbuccal permeability studies since they have
differing lipophilicities and other physico-chemical properties. Buspirone has a low
aqueous solubility and is a highly lipophilic compound which permeates primarily via the
transcellular route in the buccal mucosa (37). Bupivacaine is a moderately lipophilic
compound with a logD value of 2.48 at a pH of 6.8. Antipyrine is a moderately
hydrophilic compound and it exists in the unionized form in the physiological pH (41). It
has been used as a transcellular marker in human intestine (122). Caffeine is used as a
model hydrophilic marker in buccal permeation experiments, which permeates primaiily
through the paracellular route (72, 73).

</..?. 2

Tissue Preparation

Buccal mucosa was obtained from freshly sacrificed pigs of a local ranch (Long
Ranch Inc.). The mucosa was transported to the laboratory in isotonic phosphate buffer
(p|l

7.4) and used within two hours of animal sacrifice. The majority of underlying

connective tissue was removed with the help of a scalpel blade and then the remaining
buccal mucosa was carefully trimmed with the help of surgical scissors to uniform
thicknesses of about 500pm. The use of dermatome for the slicing of the tissue was
avoided since it requires prior freezing which may compromise the barrier properties of
,hc epithelium as well as the connective tissue region of the buccal mucosa.
thickness of foe

The

tissues was measured with the help of a digital screw gauge and

. .-corded. This helped to minimize variations between tissue specimens.
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* •'

;

Permeation Studies
1 he buccal mucosa was mounted on the side-by-side diffusion cells for

• ruuMlion studies in such a way that the epithelium faced the donor chamber and the
mviivo tissue region faced the receiver chamber.

The permeation studies were

' u ted keeping the donor and receiver chamber at five

different temperature

rtHHlilions that is 23 °C, 30 °C, 37 °C, 44 °C and 52 °C. The tissues were allowed to
.1ibr;ilc with buffer for fifteen
v Mnc.ibility experiment.

minutes before commencement of the diffusant

The permeability experiments were carried out using

pliatc buffered saline (PBS) with pH 7.4 in the receiver chamber and pH 6.8 in the
. <t chamber to mimic the in vivo physiological pH conditions(45). Permeation of the
I I diflusant compounds across the buccal mucosa was determined by collecting the

hhk c

permeation samples at every thirty minutes for up to four hours. The receiver chamber
*.*S

replaced with equal volume of PBS stored at same experimental temperature in order

maintain sink conditions. In case of bupivacaine, the sampling was done every hour
!«* up to eight hours. Experiments were conducted in triplicates and studies were done on
all the four model diffusants.

4.4

4 4,

t:ffecl 0fTemperature on

Results

the Permeability of Buccal Mucosa

I ho permeability of the model diffusants significantly increased with every 7°C
the experimental temperature (p<0.05). As can be seen in Table 4.1. the mean of
-. vc
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the permeability values of three tissues are presented with their standard deviation (Mean
± S.D.). Statistical analysis was performed using an unpaired Student's t-test, and
significant differences were accepted when the p value was < 0.05.
When enhancement factor was calculated for the increase in permeability
with temperature, it was found that the permeability of all model diffusants increased by
a factor of about 1.4 to 2.4 times for every 7 °C rise in experimental temperature (Figures
4.1, 4.2, 4.3 and 4.4).
An exponential relationship was observed between the experimental temperature
and the permeability of the four model compounds as shown in the following figure
(Figure 4.5). This relationship is more evident in Figure 4.6 as the plot of natural log ol
permeability vs the inverse of temperature (in Kelvins) yielded a linear relationship as
defined in equation (3). The activation energy of diffusion can be calculated from the
slope of these plots and using the equation (4).
A linear relationship was observed when the activation energy of diffusion was
plotted against the respective logD values of the model compounds (Figure 4.7). The data
showed that the lipophilic compounds required lesser energy for diffusion when
compared to the relatively more hydrophilic compounds.
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Figure 4.1 Enhancement in permeability of buspirone with temperature
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4.5

Discussion

Chemical penetration enhancers are being extensively studied as a way to
improve delivery of drugs across buccal mucosa. However the major limitation of these
efficient permeation enhancers is the toxicity associated with their use.

Hence an

alternative means of enhancing permeation which is safe as well as effective needs to be
investigated. A possible method of accelerating the transport of drugs across the buccal
mucosa is to apply heat or deliver the drug by locally increasing the temperature in the
buccal region.
The effect of heat as a means of enhancing transdermal and transvaginal routes of
absorption has been well documented (43, 107-114), but its effect has never been fully
explored in buccal mucosa. This temperature effect can be exploited as a means of aiding
drug delivery across the buccal mucosa. Some investigators showed an approximately
doubling of transdermal flux with each 6-8 °C increase in temperature from 10 to 60 °C
(108, 115).
Thus, there has been relatively little investigation of the effect of temperature on
buccal permeation compared to other methods of penetration enhancement. It is essential
that the effect of temperature on penetrant molecule be well defined in order to
understand the mechanism of enhancement.
Most of the permeability assessment of various drugs across buccal mucosa is
conducted in vitro using porcine buecal tissue and an experimental diffhsion assembly.
Porcine buccal mucosa has been found to be closes, in structure and permeability

properties to human

cheek(74,

75). I. serves as an excellent model to conduct in vitro

127

permeation studies of various drugs. The temperature used in permeation studies can
have a significant impact on the permeability values of different drugs across the buccal
mucosa.

Different labs use different temperature conditions in their permeation

experiments. Some labs use room temperature, 25 °C (23, 28, 59, 92), some labs use 30
(79), others use 34 °C (54, 56, 58, 60, 61, 65) whereas most of the labs use physiological
temperature 37 °C (21, 29-31, 33, 37, 66, 67, 77, 116). Lesch et al justified using room
temperature for permeation studies saying that differences between body and ambient
temperature will have minor effects and the permeation of compounds occurs by simple
diffusion across the oral mucosa and is not affected by metabolic inhibitors (92). Some
labs use Franz diffusion cells with 37 °C in the receiver chamber and 22-24 °C in the
donor chamber (24, 32, 62, 63, 68-70, 82, 83, 101, 117-119). The major shortcoming of
such an experimental setup for in vitro permeation studies across the buccal mucosa is
that it does not mimic the in vivo condition. Ideally, both the donor and receiver chamber
should be maintained at a constant temperature of 37 °C to mimic the in vivo
environment. Maintaining temperatures other than 37°C would also lead to a significant
change in the permeability data and it would be impractical to compare results from two
different labs or correlate in vitro and in vivo permeability data of these drugs. Hence, it
would be interesting to investigate the impact of the experimental temperature used in the
permeation studies on the drag permeability. One may anticipate an increase in the drug
permeability with an increase in experimental temperature, but to predict the kind of
relationship - whether it increases linearly or it increases exponentially with temperature
would be difficult unless actual experiments are conducted. It would also be interesting
to investigate whether this increase in permeability with elevated temperature is due to
128

the change in the barrier structure or decrease in integrity of the buccal mucosa. The
major advantage of this part of research would be its applicability to buccal drug
delivery. If it is observed that there is a significant increase in the permeability of the
buccal mucosa with just a small increment in temperature, then this finding can be
exploited in developing a buccal drug delivery system which utilizes this principle of
temperature increase. In that case, use of heat will be a safer alternative than the use of
hazardous and toxic penetration enhancers. However, the use of higher temperatures
(>45 °C) for a long period of time as employed in this study may cause patient
discomfort. For example, in case of certain transdermal formulations, burns (scalds) have
been shown to occur with the use of temperatures in excess of 60 °C for a short period
(120).

Hence a careful investigation into the effect of periodic increases in

physiologically acceptable temperature on transbuccal absorption and retention needs to
be done.
The objective of this work is, therefore, to evaluate the influence of temperature
on the permeation of compounds of differing lipophilicities across porcine buccal
mucosa. Buspirone, bupivacaine, antipyrine and caffeine with logD values of 2.8, 2.5,
0.39, and -0.07 respectively at a pH of 6.8 were chosen as model compounds in these
studies. These studies would also provide a basis for designing buccal drug delivery
systems that utilize increased temperature as mechanism of permeation enhancement.
The objective of the present study was to determine how the permeability of
diffusants changes with increasing temperature. The experiments were conducted at Ave
different temperatures ranging from 23 °C to 52 °C. The use of such high temperatures 45 °C and 52 °C may raise concerns, however, because of the possibility of the
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transitions in lipid structure and organization (as are known to occur in the skin's stratum
corneum (104).

However, data from the literature using buccal mucosa from dogs

suggest that irreversible effects only occur above 68 °C (105). Hence for the purpose of
the given study the temperature range used can be considered appropriate and safe. As
shown in the table 3.11, with every 7 °C rise in the temperature, the permeability of the
four model diffusants doubled in most of the times irrespective of their lipophilicities.
This indicates that it is very important to consider temperature as an important variable in
a permeation study. Care should be taken while comparing permeation data from two
different research articles if the experimental temperatures used are different.
When the enhancement ratios were calculated for all the four diffusants, it was
found that there was a 1.4-2.4 times increase in permeation with every 7 °C rise in the
temperature. In case of buspirone and antipyrine, maximum enhancement was observed
when the temperature was increased from 37 °C to 45 °C where as in case of bupivacaine
and caffeine maximum enhancement was for a temperature rise from 30 °C to 37 °C.
This enhancement in permeation of model diffusants with the aid of heat can be exploited
for commercial development of buccal delivery products. A Controlled Heated Assisted
Drug Delivery System (CHADD™) for transdermal delivery has been developed by Dr
Zhang at Zarr Pharma. CHADD is a transdermal patch which enhances the delivery of
drugs by raising the temperature of the skin via an oxidation reaction generated from a
proprietary chemical mixture (123).
It can be seen from Figure 3.19, that there exists an exponential relationship
between the permeability of a diffttsant and the experimental temperature. Hence the
permeability of the diffusants follows an Arrhenius type of relationship as discussed in
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equations 1—4. It can be also observed from the figure that the diffusants with higher
lipophilicities such as buspirone and bupivacaine showed a much steeper exponential
curve than the relatively hydrophilic diffusants such as antipyrine and caffeine. Hence
these studies show that the temperature dependence or the effect of heat on permeation
was higher for lipophilic diffusants but was much lower for relatively hydrophilic
diffusants. This is a first instance where authors have reported the temperature
dependence of permeation across porcine buccal mucosa. Due to complex nature of the
buccal mucosa, it is difficult to make detailed mechanistic conclusions regarding the
permeation pathways of the diffusants from such data alone.

However modest

conclusions can be made from calculation of the activation energy of diffusion for these
four diffusants. As can be seen from figure 3.21, a strong linear correlation was observed
between the drug's lipophilicity and the activation energy. Drugs with higher
lipophilicities such as buspirone and bupivacaine had lower activation energy of diffusion
when compared to hydrophilic drugs such as antipyrine and caffeine.
The porcine buccal mucosa acts as a permeability barrier which is attributed to the
presence of various lipids in the bilayered cell membrane or in membrane coating
granules. These lipids may undergo gel to liquid-crystalline transition as was reported in
the skin's stratum corneum (104).

However, it was shown earlier that there are no

irreversible effects occurring in the lipid structure and function in the buccal mucosa in
the temperature range employed in this experiment (105).

Also from the plots of

cumulative amount released vs. time profile, it is clear that there is no significant damage
to the permeability barrier as a steady-state flux is obtained even at a temperature of 52
°C for

all the four diffusants.

The plot of log permeability vs 1/T showed linear
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relationship in the temperature range employed, indicating that no significant structural
alteration or phase transition had occurred within the buccal mucosa. Since the lipid
transitions occur at temperatures > 68 °C, the increase in apparent permeability observed
between 23 and 52 °C in this study was primarily the result of the increased diffusion
coefficient of the penetrant in the vehicle. These values also show that when the mucosal
surface is exposed to high temperatures (52 °C as in this study), its barrier property may
be partially reduced but not lost since diffusion across the mucosa still remains the ratelimiting process in transbuccal absorption. At lower temperatures, the lipids are more
solid and less viscous which hinders the permeation of diffusants across the buccal
mucosa.

Although we cannot rule out the possibility of a reversible increase in the

fluidity of the lipids present in the buccal mucosa at temperatures of about 45 °C and 52
°C. However this temporary and reversible increase in lipid fluidity at the experimental
temperatures employed in this study may not have contributed in a major way to the
increase in transbuccal absorption.
The slope of the Arrhenius plot which is proportional to the activation energy (Ea)
gives an indication of the energy level necessary for putative penetrants to break
restraining bonds and diffuse, i.e. it provides a measure of the resistance to diffusion of
the penetrant to cross the epidermis. In general, the value of the activation energy is a
function of both the diffusing molecule and the diffusion pathway (121). Due to the
lipophilic nature of the buccal mucosa, the relatively hydrophilic diffusants such as
antipyrine and caffeine encounter greater energy barriers and therefore have higher
activation energies (75 KJ/mol) compared to the more lipophilic diffusants such as
buspirone and bupivacaine (50 KJ/mol). The lower activation energy of lipophilic
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diffusants suggests that these molecules permeate easily and fairly rapidly across the
bilayered lipid pathways. The magnitude of the activation energy, therefore takes into
account the distribution coefficients of the diffusants permeating across the buccal
mucosa.
On this basis, it was surprising that caffeine had slightly smaller activation energy
than antipyrine. This result suggests that caffeine, even though was a stronger hydrophilic
penetrant permeated the buccal mucosa more readily than antipyrine. The lower
activation energy of caffeine, in this study, however, also correlates well with the actual
values of permeability. Certain literature on the permeability of caffeine suggests that it
may traverse the skin via the lipoidal pathway (124).
The observations from these experiments will help in understanding the
mechanism of the effect of elevated temperature on the in vitro transbuccal permeation. It
will also help in predicting the permeation enhancement of model drug compounds with
increase in the temperature. This knowledge can be utilized and exploited in development
of buccal drug delivery systems based on temperature elevation.

4.6 Conclusion
The permeability of model compounds increased exponentially with
temperature. Drugs with higher lipophilicities such as buspirone and bupivacaine had
lower activation energy of diffusion when compared to hydrophilic drugs such as
antipyrine and caffeine. It was found that the activation energy of diffusion of the model
compounds decreased linearly with increasing distribution coefficients across porcine
buccal mucosa.
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CHAPTER 5
CONCLUSIONS

The barrier nature of the buccal mucosa increased with an increase in tissue
thickness for all diffusants irrespective of their physico-chemical properties. The buccal
mucosa is a heterogeneous membrane comprising of two regions - the epithelium and the
connective tissue each contributing in different proportions towards the barrier properties.
The epithelium acts as a major permeability barrier to diffusion of molecules, however
the relative contribution of the connective tissue region in barrier function increases with
increasing tissue thickness.

The epithelium acts as a stronger barrier up to a total

mucosal thickness of 500 pm for all diffusants irrespective of theii physico-chemical
characteristics. The connective tissue acts as a major barrier at a mucosal thickness of
700 pm for all the four diffusants studied. The diffusion coefficient of the epithelium is
significantly higher than the connective tissue diffusivity irrespective of the lipophilicity
of the diffusants. The epithelium acts as a greater barrier to diffusion of hydrophihc
diffusants when compared to the relatively more lipophilic diffusants.
The permeability of the model diffusants is affected by the site of excision of the
buccal mucosa used in permeation studies. The region behind the lip has lower epithelial
thickness which results in a higher permeability of model diffusants when compared to
the middle- cheek region.
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From the results of experiments conducted on various storage conditions employed, it
was concluded that for the purposes of assessing drug permeability in vitro, the
appropriate storage time would be up to 24 hours in KBR at 4 °C as this would avoid
artefacts in the permeability data. Heat separation of buccal epithelium did not adversely
affect the permeability and integrity characteristics of the porcine buccal epithelium.
While conducting in vitro permeability studies across porcine buccal mucosa, it is highly
recommended that fresh tissues are used and that the tissues are excised from the same
site of buccal region. It would be better to use heat separated epithelia since complete
removal of connective tissue is possible only with this processing method without any
compromise in tissue integrity and permeability characteristics.
The permeability of model compounds increased exponentially with temperature.
Drugs with higher lipophilicities such as buspirone and bupivacaine had lower activation
energy of diffusion when compared to hydrophilic drugs such as antipyrine and caffeine.
It was found that the activation energy of diffusion of the model compounds decreased
linearly with increasing distribution coefficients across porcine buccal mucosa.
The current dissertation research involved the understanding of the drug delivery
barrier provided by buccal mucosa and other mucosal membranes. Specifically, it dealt
with understanding the mechanisms by which different biological and experimental
factors alter the diffusion of various drugs across the epithelial membrane. The outcome
of this research provides an optimized set of conditions and a future basis for conducting
in vitro permeability studies across porcine buccal mucosa which would mimic the in
vivo drug absorption. This research work increases our understanding of how the drugs
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are absorbed via the buccal route and provides a scientific basis to develop buccal
mucosa as a potential and novel drug delivery route.

Future Work:
The current research work used low molecular weight diffusants with their logP
values ranging from -0.07 to 2.8. It was found that the permeability of heat separated
epithelium was similar to the surgically isolated epithelium. However, future work needs
to be done to see its applicability with sufficiently hydrophilic and high molecular weight
diffusants such as peptides and proteins.
Since the biological and experimental conditions have now been optimized to
carry out in vitro studies, the next step would be to conduct in vivo permeability studies
in humans and determine the in vitro — in vivo correlation. It would be very interesting to
observe which of the in vitro permeability data; using either heat-separated or surgically
isolated epithelium; correlates well with the in vivo performance.
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